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Abstract 
 
Atherosclerosis is a progressive disease that leads to plaque development and is associated with 
cardiovascular events such as myocardial infarction and stroke.  Several biomarkers have been 
established as surrogates of plaque development yet none can provide direct, noninvasive, rapid 
measurements of atherosclerotic disease. Three-dimensional Ultrasound (3DUS) image acquisition 
is safe, inexpensive and fast, however 3DUS image measurements are limited due to time 
consuming manual image analyses.  In addition, the true clinical meaning of 3DUS carotid imaging 
measurements has not yet been established. A semi-automated approach for the estimation of 3DUS 
Total Plaque Volume (TPV) was developed with similar variability and high agreement with 
manual measurements.  3DUS measurements such as Vessel Wall Volume (VWV) and TPV were 
shown to have similar associations of plaque and Intima-media Thickness (IMT) with age in males 
however this relationship did not exist in females.  3DUS measurements of carotid atherosclerosis 
can provide a more sensitive estimation of disease burden in vulnerable patient populations than 
traditional measures.  
 
Keywords: Atherosclerosis, Stroke, Age, Sex, Three-dimensional Ultrasound, Vessel Wall 
Volume, Total Plaque Volume, Semi-automated, Validation 
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Chapter 1: Introduction 
 
1.1 Overview 
Cardiovascular disease (CVD) is projected to be the number one cause of global mortality in 2020 
with ischemic heart disease as the leading cause and cerebrovascular disease as the second leading 
cause of mortality.1  Causes of ischemia stem from atherosclerotic disease of the vessels, a common 
precursor in ischemic stroke and heart disease.  In recent years, the mortality rate of CVD in 
developed countries has stabilized due to management of modifiable risk factors.2  In low and 
middle income countries however, cardiovascular disease mortality continues to rise due to 
inadequate treatment and limited prevention of risk factors for CVD. 3, 4  Of these deaths, stroke 
causes approximately 5.7 million deaths per year or 10% of all deaths.5  This number is expected to 
rise to 7.8 million deaths worldwide by 2030.6  Ischemic strokes are the most common form 
accounting for 87% of all strokes.2  In Canada, treatment of ischemic stroke costs over $50,000 per 
year for each patient and 73% of those who experience stroke will access health care again within 
the next 5 years.7, 8 
Atherosclerosis is a disease of the arteries whereby circulating factors provoke an inflammatory 
response that often leads to the formation of plaque.  This disease not only plays a role in stroke but 
also causes coronary events such as myocardial infarction.  Large longitudinal observational studies 
have identified modifiable risk factors for stroke such as hypertension, abdominal obesity, diet, 
smoking and physical inactivity.9  Treatment and monitoring of atherosclerosis and its 
manifestations depends on methods of plaque detection.  Effective strategies for reducing 
cardiovascular disease require sensitive measurements that are safe, non-invasive assessment 
techniques that can be widely adopted. 
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Within the past 30 years imaging modalities such as ultrasound have been proven to be valuable in 
characterizing atherosclerosis.10  Three-dimensional ultrasound (3DUS) imaging phenotypes have 
been previously developed, however the understanding of their clinical meaning is unclear and 
translation of these tools into clinical practice has been delayed.  The first section of this thesis 
focuses on establishing carotid ultrasound imaging phenotypes. The relationships between different 
measurements of atherosclerosis are explored through comparison and are also related to age.  The 
second section describes the development of a semi-automated measurement which quantifies 
carotid artery plaque volume.  Semi-automated segmentation measurements such as this increase 
the clinical potential of research tools. 
 
1.2 Anatomy 
Atherosclerosis is a progressive disease that commonly occurs in mid to large arteries of the 
vasculature.  The carotid arteries are of particular physiological importance as they supply the brain 
(internal carotid artery (ICA)) and facial tissue (external carotid artery (ECA)) with oxygenated 
blood.  The ascending aorta is supplied with blood from the left ventricle of the heart.  The left 
common carotid artery branches off of the aortic arch and transports oxygenated blood to the brain 
and face.  The right common carotid artery stems from the brachiocephalic artery which also 
branches from the aortic arch.  Proximal to their origins each common carotid artery bifurcates into 
the internal and external carotid arteries as shown in Figure 1-1. 
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Figure 1-1.  Carotid Artery Anatomy.  The common, internal and external carotid arteries and 
structural layers of the artery.  Arteries in the neck adapted from11 vessel composition adapted 
from12. 
 
The carotid arteries are composed of several adjacent layers each of which has unique structural 
properties.  The innermost layer of the artery is the intima.  Endothelium lines the lumen-intima 
boundary, a thin layer comprised of endothelial cells.  These cells are connected by tight junctions, 
which contribute to one of the functions of the endothelium; to act as a barrier to prevent 
components of the blood diffusing out of the vessel lumen.13  Endothelial cells also secrete 
important factors that help regulate adhesion of molecules that maintain the tone of the vessel 
through vasoconstriction and dilation.  The intima is also comprised of some smooth muscle cells, 
collagen, proteoglycans and an elastic component.  The internal elastic lamina separates the intima 
from the adjacent media layer.  The media is primarily comprised of smooth muscle cells however 
it also contains collagen and elastic components.  The surrounding adventitia is the outermost layer 
of the artery consisting mostly of connective tissue and some smooth muscle cells and fibroblasts14.  
The adventitia attaches the artery to surround tissue. 
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1.3 Risk Factors 
Cholesterol levels have historically been used as a predictor of coronary heart disease15.  Low 
density lipoprotein (LDL) is responsible for the transport of cholesterol to cells.  However in its 
oxidized form it is toxic to the arterial wall and contributes to atherosclerosis and plaque 
development16.  Apolipoprotein B is the main protein found in LDL and is considered to be a better 
predictor of ischemic events than cholesterol levels.17  Apolipoprotein B is found not only in LDL 
but also intermediate density lipoprotein, very low density lipoprotein, and chylomicrons all of 
which are considered to promote atherosclerosis.17 
Longitudinal observations of cardiovascular outcomes have been important in identifying risk 
factors for heart disease and stroke.  Cardiovascular risk scores have been generated from 
observations in populations monitored over time.  The Framingham Heart Study followed 2489 
men and 2856 women over a period of 12 years to identify and categorize 10-year risk of heart 
disease derived from a point system that uses age, LDL cholesterol levels, HDL cholesterol levels, 
blood pressure, diabetes and smoking to calculate a risk score.15  Various risk score systems have 
been created (SCORE, WHO/ISH, Reynolds Risk Score, QRISK, PROCAM, ASSIGN) which 
identify ischemic heart disease risk factors that are also risk factors for stroke.18-24  Several 
modifiable risk factors for stroke have been identified such as hypertension, smoking, abdominal 
obesity, diet and physical inactivity.9 
Hypertension or elevated blood pressure is defined as systolic blood pressure > 140 mmHg and 
diastolic > 90 mmHg with increased systolic blood pressure hypertension more common.25  Risk of 
developing hypertension increases with age with lifetime risk > 85% in women and > 80% in 
men.26  Hypertension has been suggested to be the principal determinant of atherosclerosis.27  
Detection and management of blood pressure is important in stroke prevention as a 20 mmHg 
systolic or 10 mmHg diastolic increases mortality rates twofold.25 
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Smoking and passive exposure to tobacco smoke measured in pack-years are contributors to 
atherosclerosis disease of the arteries.  The effects of smoking appear to be cumulative as there is 
no association between smoking status and the progression of the disease.28  Smoking has been 
shown to have effects on vasculature decreasing the ability of the vessel to stretch and thus 
affecting blood vessel compliance which is defined as the change in volume divided by change in 
pressure.12, 29  In addition to structural effects, smoking also causes changes in properties of the 
blood.  For example, smoking stimulates an inflammatory response in the arteries and increases 
blood viscosity.30  Increased hematocrit and elevated levels of white blood cells and fibrinogen in 
response to tobacco smoke could contribute to atherosclerosis. 
The Northern Manhattan Stroke Study identified obesity as an independent risk factor for ischemic 
stroke particularly among those < 65 years of age.  Obesity was identified as a stronger predictor of 
stroke than body mass index (BMI).31  It is hypothesized that adipose tissue secretes cytokines 
which have similar effects on endothelial function as seen in diabetes.32  Katsiki et al. describe the 
obesity-stroke paradox where following stroke, obese patients have a lower risk of mortality than 
those with normal BMI.33  The advantageous effects of obesity following stroke remain unclear. 
Diabetes is also a co morbidity associated with stroke increasing the risk of ischemic stroke due to 
factors relating to insulin resistance.34  The processes that characterize this disease have significant 
impacts on endothelial cells.  Hyperglycemia, dyslipidemia and insulin resistance all contribute to 
endothelial dysfunction.  In the early stages of atherosclerosis, diabetes conditions lower levels of 
nitric oxide which results in vasoconstriction, inflammation and thrombosis.35   
Alcohol intake has been identified as a risk factor for stroke.36  The amount of alcohol consumption 
has been linked to different outcomes.  While there is uncertainty surrounding the effects of low to 
moderate intake,37 heavy drinking or binge drinking (300 g/wk) has been shown to increase the risk 
of stroke by a factor of four.38  Although hemorrhagic stroke is less common, studies have also 
shown that heavy drinking has increased risk of stroke.39  Many studies have used self-reported 
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alcohol consumption which often underestimates frequency of drinking alcohol while other 
biomarkers such as serum gamma-glutamyl transferase may provide a more objective measure of 
intake.40  In large amounts, alcohol raises blood pressure, has the potential to disrupt plaques and 
can cause cardiomyopathy.36  There has been some evidence that indicates that moderate alcohol 
intake can protect against ischemic stroke increasing high density lipoproteins (HDLs), 
plasminogen activator, insulin sensitivity and decreasing lipoprotein (a), platelet aggregation and 
fibrinogen.37, 41 
Psychosocial factors have also been linked to stroke events.  While a number of different factors 
could potentially contribute, depression has been associated with stroke mortality.  Over a 29 year 
time period, depressive symptoms increase the risk of stroke mortality by 50%.42 
Physical activity and diet have effects on insulin and lipid levels as well as endothelial function.  
Exercise is hypothesized to lower lipids, improve insulin sensitivity, have anti-thrombotic effects 
and prevent endothelial dysfunction through effects on inflammatory cytokines.43  Physical activity 
also has hypotensive effects decreasing resistance of the arteries and promoting function of 
endothelial cells.44  Diet also plays an important role in atherosclerosis as animal studies have 
shown low-cholesterol diets can contribute to the stability of plaques.45 
While all of the risk factors discussed here are modifiable, there are certain factors that increase 
stroke risk which are predetermined.  Age, sex, race and family history determine predisposition to 
stroke.46, 47  Increased age is a central predictor of stroke risk.  In fact, stroke risk doubles every 
decade after the age of 55.48  Aging causes remodelling of the arteries such as fracturing of elastin, 
increased collagen levels and calcification within the intima resulting in arterial stiffening leading to 
reduced compliance49.  Compliance is also affected by hormone levels as increases in compliance 
have been shown in post-menopausal women on hormone replacement therapy.50 
There are a number of emerging risk factors for vascular disease that may provide more accurate 
prediction of stroke events. These biological factors include biomarkers of inflammation, 
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thrombosis, platelet characteristics and activity, lipids and associated molecules as well as other 
factors.51  C-reactive protein is an acute-phase protein produced by the liver in response to tissue 
injury.  Increases in levels of c-reactive protein are associated with coronary heart disease and 
indicate the presence of inflammation, a component of arterial atherosclerotic disease.52 This acute-
phase protein is associated with obesity and diabetes and may up-regulate endothelial cell adhesion 
and LDL oxidation by macrophages.53-55 
Lipoprotein (a) (Lp(a)) is also associated with vascular disease.  This biomarker is an indicator of 
stroke and is associated with increased mortality.56, 57  Lipoprotein (a) resembles LDL and is 
composed of a protein component (apo B100) covalently bonded to a glycoprotein (apolipoprotein 
(a)).58  Circulating Lp (a) is thought to promote thrombosis as this molecule is similar in structure to 
plasminogen and may inhibit its functions.59 It also promotes atherosclerosis as levels of lipoprotein 
(a) rise in response to inflammation increasing smooth muscle cell migration and transport of 
cholesterol to the site of plaque development.60  Levels of serum Lp (a) have been shown to be 
genetically determined with increased levels associated with atherosclerosis.57 
Fibrinogen is another emerging biomarker that has received attention in identifying precursors of 
plaque development.  Fibrinogen is a glycoprotein which is converted by thrombin to fibrin a 
clotting factor that functions in end stages of coagulation.61  Thus, fibrinogen has potential effects 
on thrombosis.  Elevated levels of this glycoprotein have been correlated with plaque and intima-
media thickening.62 
Homocysteine is an amino acid involved in methionine metabolism which has been shown to be 
elevated by approximately 20% in those who experience stroke.63  Homocysteine is thought to 
promote vascular disease through multiple mechanisms.  One such mechanism is promoting 
thrombosis by increasing coagulation.64  Additionally, homocysteine acts as a catalyst in the 
production of hydrogen peroxide causing damage to endothelial cells.65  Individuals with 
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homocystinuria, an autosomal recessive disease, are at an increased risk of developing accelerated 
atherosclerosis in addition to other complications.64 
 
1.4 Carotid Atherosclerosis and Classification of Plaque 
In the past, theories that describe the process of atherosclerosis have focused on accumulation of 
cholesterol, however, inflammation has been identified as an essential component in the 
pathophysiology of this disease.53  Monocyte chemotaxis is an essential step in the initiation of 
plaque development.  The probability of leukocyte adhesion is increased in areas of nonlaminar 
flow where turbulence creates a pooling affect at areas of low shear stress and increases the 
potential for interaction between circulating molecules and endothelial cells.  Oxidized LDL 
particles within the intima provoke the recruitment of monocytes and stimulate changes in the 
endothelium. Leukocyte migration into the intima is caused by increased adhesion and permeability 
of the endothelium due to an increase in the levels of receptors expressed on these cells66.  Once 
monocytes have penetrated the endothelial barrier, they are transformed into macrophages which 
phagocytose oxidized LDL particles.  Oxidized LDL particles increase activity of matrix 
metalloproteinases, smooth muscle cell apoptosis and impair nitric oxide production16. 
Plaques have been categorized by the American Heart Association into six stages of development.67, 
68
  In the initial stages of early plaques, macrophages accumulate cholesterol forming foam cells.  
Foam cells are only visible under microscope however contribute to intimal thickening and are 
classified as Type I plaques.  Multiple foam cells produce spots or streaks along the endothelium.  
The increase in foam cells is due to the auto-amplification phenomenon where foam cells release 
cytokines which stimulate the immune response.66  Chemotaxis of monocytes leads to the 
production of more foam cells and subsequently more chemokines.  Layering of foam cells in 
combination with mast cells, T lymphocytes and smooth muscle cells characterize type II lesions. 
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A preatheroma or intermediate plaque is classified at a type III lesion.  Separate lipid pools are 
formed due to accumulation of extracellular lipids beneath layers of foam cells.  Lipid pools lead to 
the reorganization of smooth muscle cells in the intima causing thickening of this layer.  
Disorganization of the intimal layer due to additive effects of multiple lipid pools results in the 
formation of a lipid core.  The lipid core is the distinguishable feature of Type IV (atheroma) 
lesions which along with type III lesions could lead to erosion and formation of a thrombus.  Foam 
cells in combination with mast cells, T lymphocytes and smooth muscle cells are found in between 
the endothelial layer and the lipid pool which is surrounded by vasa vasorum originating from the 
adventitia layer. 
 
 
 
 
 
Figure 1-2.  Stable atheroma indicating direction of plaque progression.  Lumen occlusion is 
absent in early stages of plaque formation as artery compensates to maintain normal blood flow 
(light blue).  In later stages of plaque development stenosis occurs (dark blue).  Adapted from69. 
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Glagov describes the progression of plaque in relation to lumen area which is indicated in Figure 1-
2.  As the intima layers thicken the vessel compensates, growing outward and preventing 
obstruction of flow.  The artery expands until the plaque has occupied 40% of the internal elastic 
lamina at which point the lesions begins to encroach into the lumen. Compensatory enlargement of 
the vessel preserves unobstructed flow in the lumen until late stages of atherosclerosis.70 
Fibroatheroma or Type Va lesions have fibrous cap development around the lipid core composed of 
smooth muscles cells and collagen.  The fibrous cap is developed to separate the lipid core from the 
arterial lumen.  Type Vb lesions are characterized by calcification from smooth muscle cell secreted 
osteopontin.  Type Vc lesions are typically termed fibrous plaque where lipid levels decline and are 
replaced with connective tissue.   
The final lesion type classifies complicated lesions often associated with cerebrovascular events.  
While type VIa lesions include plaques with ulcerations and fissures, type VIb refers to lesions with 
hemorrhage of vasa vasorum within the plaque and type VIc are lesions involved in thrombosis due 
to external mechanical forces from blood flow.71 
 
1.5 Treatment of Atherosclerosis 
Lifestyle factors such as physical activity and exercise can be altered to prevent plaque formation 
and slow arterial disease.72  Deviation from atherogenic diets to diets which reduce cholesterol 
levels decreases intimal area by approximately 60% and reduces foam cells and inflammation of the 
artery.73  Dietary intervention slows progression of vascular disease and promotes regression of 
plaque, an outcome which can be improved when combined with drug therapy.74 
 
 
 
11 
 
1.5.1 Drug therapy 
When primary interventions alone are no longer sufficient, therapies which target specific risk 
factors can be effective in reducing cardiovascular event risk and disease progression.  LDL was 
previously mentioned as a risk factor for stroke and is an important component in the formation of 
plaque.  Serum LDL levels can be lowered with statin therapy, a group of HMG-CoA reductase 
inhibitors that lower the production of cholesterol in the liver.75  HMG-CoA reductase is an enzyme 
involved in the rate-limiting step of cholesterol synthesis.76  Inhibition of its activity leads to 
reduced levels of LDL cholesterol formed and increased LDL receptors.75  In the Cholesterol and 
Recurrent events trial (CARE), pravastatin was shown to reduce stroke by 32% following 
myocardial infarction.77  Atorvastatin treatment of 80 mg per day reduced risk of stroke by 33% 
with the greatest benefits seen in subjects with carotid stenosis.78  Other statins such as simvastatin 
have shown to reduce mortality79 and have a similar reduction in ischemic stroke of approximately 
30%.80 
Management of co-morbidities is also an important factor in treatment of atherosclerosis.  Several 
mechanisms have been identified to lower blood pressure.12  ACE inhibitors such as ramapril 
prevent the conversion of angiotensinogen to angiotensin II inhibiting its actions.  Actions of 
Angiotensin II lead to increased blood pressure and include vasoconstriction, increased sympathetic 
output to the cardiovascular system, increased vasopressin, elevated levels of aldosterone and thirst.  
A meta-analysis of antihypertensive therapies estimated from placebo-controlled trials that ACE 
inhibitors reduced the risk of cardiovascular events by 20-30%.81  Beta blockers and diuretics are 
also used to treat hypertension and do not differ significantly in treatment effects in relation to 
morbidity and mortality.82 
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1.5.2 Surgical Intervention 
Surgical intervention in late stage atherosclerosis has potential benefits in reducing stroke risk.  The 
North American Symptomatic Carotid Endarterectomy Trial (NASCET) identified significant 
benefits in carotid endarterectomy procedures for symptomatic subjects with significant stenosis 
(>70%) and in those with moderate stenosis (50-69%) benefits were also observed.  Other large 
scale surgical trials including the European Carotid Surgery Trial have reported similar benefits for 
endarterectomy in symptomatic patients with severe stenosis.83, 84  Similar studies evaluating the 
benefits of carotid endarterectomy (stenosis >60%) in asymptomatic subjects have shown a 66% 
five-year stroke risk reduction in men post-endarterectomy compared to 17% in women.85 
Another surgical treatment which restores plaque-impeded blood flow is carotid angioplasty and 
stenting.  A wire is inserted through either the femoral or carotid artery and guided to the site of the 
lesion where a balloon catheter expands the artery for stent placement.  Stenting has been shown to 
produce similar outcomes in mortality and stroke and may provide an advantage over 
endarterectomy as shorter hospitalization have been reported.86  Neurological complications such as 
disruption of plaque and emboli limit this intervention.87  While surgical interventions provide 
treatment for advanced lesions, primary interventions which aim to prevent plaque formation are 
the most effective in reducing stroke mortality. 
 
1.6 Imaging Carotid Arteries 
1.6.1 X-Ray Based Methods 
Angiography is an imaging technique that uses contrast agents and x-ray to assess structural 
changes in coronary or carotid artery lumen.  X-ray angiography is useful in detecting calcification 
within plaque and narrowing of the artery due to thickening of the fibrous cap and associated 
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inflammatory activity.  Extent of luminal stenosis is important in determining whether surgical 
intervention is necessary.  This method is an important tool for late stage lesions however it does 
not provide useful information of early stage plaques.  This imaging modality is limited in 
accurately detecting reduction in luminal area as atherosclerosis can be diffuse and comparisons to 
neighboring normal segments may not be representative due to the presence of plaque in these 
regions.88  While x-ray angiography provides information pertaining to stenosis of the artery, 
stenosis is not the exclusive cause of ischemic symptoms.  Symptoms can be caused by ulcerated 
lesions, while additionally significant stenosis can result in asymptomatic patients.85, 89 
 
1.6.2 Magnetic Resonance Imaging (MRI) Methods 
Magnetic Resonance imaging (MRI) utilizes molecular spin properties of protons within the body, 
an external magnetic field generated by a powerful magnet and radiofrequency pulses to generate 
an image.  MRI can provide pertinent information in describing atherosclerosis burden such as 
plaque composition and luminal stenosis which has been validated with histopathology.90  While 
bright-blood pulse sequences suppress tissue surrounding blood flow enabling identification of 
luminal stenosis, this method often produces signal void due to abnormal flow.  Black-blood 
imaging techniques are preferable as suppression of blood flow signal allows for visualization of 
arterial wall structures.91  Using various contrast agents such as gadolinium and ultrasmall 
superparamagnetic particles of iron oxide (USPIO) is important in increasing image resolution and 
distinguishing between plaque components.92-95  MRI is limited in that it is an expensive imaging 
modality that is also time intensive.  However, characterization of plaque and its surface 
irregularities from MRI techniques has been shown to correlate well with ischemic symptoms.96 
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1.6.3 Ultrasound Imaging Methods 
Ultrasound imaging is a safe, noninvasive technique for characterization of vascular disease.  A 
piezoelectric transducer generates mechanical waves that penetrate tissue.  As the wave travels 
through various structural components it is attenuated and reflected back to the probe where 
variations in reflected acoustic waves are detected and transformed into an image.  Quantifying 
atherosclerosis using ultrasound imaging is highly dependent on image acquisition and optimization 
settings selected by the sonographer. 
 
1.6.3.1 Intravascular Ultrasound (IVUS) 
Intravascular ultrasound (IVUS) provides information of plaque size and morphology and has been 
validated with histopathology post-mortem.97, 98  A catheter with a small ultrasound transducer 
rotates within the artery and is advanced or retracted while ultrasound images of the surrounding 
tissue are recorded for analysis.99  High frequency probes produce high resolution images of vessel 
wall layers and plaque composition.  Lipid deposits present as hypoechoic while fibrous tissue and 
collagen produce a bright signal.100  Table 1-1 compares resolution, radiation dose, and 
invasiveness for IVUS and other imaging modalities discussed in this chapter.  Lumen area is 
estimated using planimetry by outlining the lumen-intima boundary,101 however the thickness of the 
intima and medial layers is at times hard to distinguish.98  While this modality has numerous 
advantages over x-ray angiography, this method is limited by certain factors.  IVUS is an invasive 
procedure with the potential to disrupt plaque and cause thrombosis.  Furthermore although it can 
distinguish plaque and calcification, it is limited in imaging of thrombi, soft plaque and hard 
plaque.99 
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Table 1-1. Invasiveness, Radiation Dose and Resolution of Atherosclerosis Imaging Methods.  
Adapted from Tardif et al. 2011.102 
 
Imaging Modality Invasive Radiation Resolution 
Coronary angiography + + 0.4 mm 
IVUS +, catheter - 0.08-0.10 mm 
Carotid Ultrasound - - 0.15 mm 
 
 
1.6.3.2 Doppler Ultrasound 
Doppler ultrasound has been recognized by the Society of Radiologists in Ultrasound as an 
important tool in measurement of carotid artery imaging and is suggested for characterizing internal 
carotid artery stensosis.103  The Doppler Effect is described as the observed change in frequency of 
a longitudinal wave due to motion between an observer and the source of the pressure wave.104  
Blood flow velocity is determined through acquisition of reflected ultrasound frequencies which 
generate a Doppler shift that can be displayed visually with Colour Doppler.   
This tool has the ability to identify lesions which are associated with altered flow patterns as 
determined by laser velocimetry.105  Doppler ultrasonography is also useful in estimating aortic 
compliance non-invasively using pulse wave velocity which is inversely related to compliance.  
Risk factors for CVD and cardiovascular events are associated with stiffer aortas when compared to 
healthy controls.106 While Doppler provides a safe and inexpensive assessment of patients for 
therapy or endarterectomy, endothelial dysfunction indicated by abnormal acetylcholine response 
has been shown in patients with nonsignificant Doppler findings for vascular disease.107  Early stage 
evaluation of atherosclerosis may be inadequate and made worse by variation between operators. 
 
1.6.3.3 Carotid B-mode Ultrasound 
B-mode or “brightness” mode ultrasound uses a transducer, which is placed on the surface of the 
skin where it generates ultrasonic longitudinal waves that penetrate tissue.  The pulse generated is 
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reflected differently depending on composition of various structures which creates echoes of 
varying intensity which travel back to the trasnducer.  This pulse-echo method is used to map out 
underlying structures with more reflective materials appearing brighter.  B-mode ultrasound is a 
well-established imaging modality and thus is commonly used in the clinical realm. Ultrasound 
imaging phenotypes have been developed to objectively measure atherosclerosis from B-mode 
images.108 
The intima-media thickness (IMT) is a measurement of the intimal and medial layers in the far wall 
of the artery for a 10 mm wall segment of the common carotid artery (CCA), carotid bulb or ICA.109  
Intima-media thickness as illustrated in Figure 1-3 has been identified as an endpoint for clinical 
studies and has been correlated with stroke and myocardial infarction.110  Intima-media thickness 
has shown to be significantly but modestly positively associated with cardiovascular risk factors 
such as systolic blood pressure, LDL cholesterol, triglycerides, blood glucose and inversely 
correlated with HDL cholesterol.111, 112 
 
Figure 1-3.  B-mode ultrasound intima-media thickness.  IMT measurement in red generate from 
intima-lumen and media-adventitia interfaces for 10mm of the common carotid artery. 
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IMT has been suggested to represent biological processes other than plaque development  as plaque 
grows 2-4 times faster in length than in thickness.113  Plaque is also a disease of the intima. Since 
the intima is quite thin, the IMT measurement is mostly reflective of medial thickening.114 
Total Plaque Area (TPA) is a two-dimensional measurement of carotid plaque area using B-mode 
ultrasound.  In a longitudinal view, cross-sectional areas of plaque are measured in the internal, 
external and common carotid arteries and all areas are summed.  TPA has been shown to be a risk 
factor for clinical cardiovascular symptoms.115  This phenotype is also useful in evaluating 
interventions as folic acid, Vitamin B6 and Vitamin B12 treatment have been shown to reduce TPA 
in patients with elevated homocysteine at increased risk for atherosclerosis.116  Significant change 
(regression or progression) in total plaque area for longitudinal comparisons is defined as ≥ 0.05 
cm2 while plaque is defined as intima-media thickening > 1mm.115, 117  Longitudinal comparisons of 
TPA may however be limited in that cross-sectional areas measured at different time points may be 
taken at different locations within the plaque.  Cross-sectional areas are identified by the observer 
and thus are subjective.  Additionally, TPA provides information of plaque length and residence 
along the artery however this measurement does not accurately estimate the shape or volume of 
plaque. 
 
1.6.3.4 Three-Dimensional Ultrasound (3DUS) 
Three-dimensional ultrasound (3DUS) systems construct 3D ultrasound images using traditional 1-
dimensional transducers.  Several parallel 2D images are collected and digitized within a 3D 
volume to be reconstructed into a 3D image.  Scanning methods include mechanical scanning, free-
hand or 2D array.  Optimal scanning utilizes mechanical acquisition which rapidly acquires 2D 
frames and prevents motion artefacts.  Additionally, parallel 2D images are of the same orientation 
and are equal spaced, which allows for simple linear interpolation of pixels to create 3D voxels.118 
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1.6.4 Emerging 3DUS Imaging Phenotypes 
1.6.4.1 3DUS Carotid Vessel Wall Volume 
In contrast to IMT measurements that are commonly generated at the carotid bulb and do not 
include atherosclerotic plaque lesions, 3DUS vessel wall volume (VWV) provides a 3D 
circumferential wall and plaque volume measurement that has been shown to be sensitive to 
longitudinal changes 119-121 even in subjects without echogenic plaque or significant changes in 
intima-media thickness. 122, 123  The VWV is shown in Figure 1-4. 
Figure 1-4.  Three-dimensional ultrasound (3DUS) vessel wall volume (VWV).  Cross-sectional 
areas in the axial view are segmented and multiplied by the interslice distance (1 mm) to calculate a 
volume.  Lumen-intima boundary (blue) is subtracted from media-adventitia boundary (red) to 
calculate the wall volume of the common carotid artery.  The volume of the internal common 
carotid (proximal to bifurcation, BF) is calculated as the difference in cross-sectional areas of the 
media-adventitia boundary (yellow) and the lumen-intima boundary (green).  The internal and 
common carotid artery volumes are summed to generate the total VWV. 
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The high reproducibility of the vessel wall volume measurement124 has been demonstrated with the 
intra-observer coefficient of variation of 6.5% when compared to 4.7% for IMT.  The inter-scan 
coefficient of variation for VWV has been shown to be 13.5% compared to 8.9% for IMT.125  
Additionally, intrascan variability of VWV has also been reported with a coefficient of variation of 
4.6% and an intraclass correlation coefficient of 0.95.  The interscan reproducibility of VWV was 
demonstrated with a coefficient of variation of 5.7% and an interclass correlation coefficient of 
0.85.124  Egger et al. have also shown in a study of five subjects with carotid stenosis, no significant 
difference between subjects at scan and rescan two weeks later.126  Additionally, Krasinski et al. 
analyzed subjects receiving atorvastatin treatment at baseline and three months later with 
comparison to a control group. Those receiving treatment showed a significant change between 
scan and rescan as VWV increased by 70 ± 140 mm3 (+4.9 ± 10.3%) in the placebo group and 
decreased by 30 ± 110 mm3 (-1.4 ± 7.7%) in the atorvastatin group (p < 0.05).127  VWV can be used 
to generate carotid artery thickness maps indicating regions of atherosclerosis along the carotid 
artery.126 
 
1.6.4.2 3DUS Carotid Total Plaque Volume 
Total Plaque Volume (TPV) is a 3D ultrasound measurement that estimates the total amount of 
plaque within the carotid arteries.  Areas of hyperechoic signal are measured indicating the presence 
of calcification.  Currently, this method uses manual planimetry to outline plaque areas slice by 
slice.  The interslice distance between two slices is multiplied by the average area of those slices to 
generate an incremental volume.  All incremental volumes are added to generate the total plaque 
volume.  This method is time consuming taking upwards of 7 minutes for the generation of one 
plaque volume as the observer may have to manually trace plaque areas for 30 slices per plaque.128  
Although time consuming, the accuracy of this measurement has been demonstrated using agar test 
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phantoms ranging from approximately 70 mm3 to 285 mm3 with a mean accuracy of 3.1 +- 0.9%.129  
Landry et al have identified a decreasing trend in the coefficient of variation for increasing plaque 
volume using the manual planimetry method.130, 131 
 
Figure 1-5.  Three-dimensional ultrasound (3DUS) total plaque volume (TPV).  Cross-sectional 
areas in the axial view are segmented and multiplied by the interslice distance (1 mm) to calculate a 
volume. 
 
 
1.7 Research Hypothesis and Objectives 
We hypothesize that three-dimensional ultrasound measurements of carotid atherosclerosis can 
provide a more sensitive estimation of disease burden in vulnerable patient populations than 
traditional measures.  Two primary objectives of this thesis are to 1) characterize the relationship of 
three-dimensional ultrasound vessel wall volume with age and 2) develop a novel semi-automated 
approach for the estimation of total carotid plaque volume.  The objectives described here were 
developed to provide rapid estimation of atherosclerotic disease and improve our understanding of 
interpreting 3DUS measurements as they relate to cerebrovascular event risk. 
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In Chapter 2, we investigate the relationship between ultrasound imaging phenotypes and age.  
Intima-media thickness, vessel wall volume and total plaque volume measurements were correlated 
in subjects with moderate disease.  We hypothesize that age will correlate with 3D ultrasound 
phenotypes such as vessel wall volume and total plaque volume with similar strength of association 
established previously between age and traditional two dimensional ultrasound measurements such 
as the intima-media thickness. 
In Chapter 3, we investigate total plaque volume as a potential clinical tool for the sonographer to 
utilize at the bedside.  The semi-automation of this measurement allows for rapid estimation of 
plaque burden post scan.  We hypothesize that the semi-automated total plaque volume 
measurements will yield similar intraobserver and interobserver variability in comparison to the 
manual segmentation method.  Comparisons of semi-automated measurements to a manual 
reference standard are described to demonstrate accuracy of the novel approach. 
The current limitations of three-dimensional ultrasound measurements are explored in Chapter 4 
and recommendations are made for future work in establishing these phenotypes as clinical tools. 
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Chapter 2: The Relationship of of Carotid Three-
Dimensional Ultrasound Vessel Wall Volume with Age 
and Sex: Comparison to Carotid Intima-media 
Thickness 
 
2.1 Introduction 
Ultrasound imaging of the carotid arteries is a relatively low-cost and direct method for generating 
regional measurements of arterial wall thickness and plaque 1-3.  Such ultrasound (US) 
measurements of carotid atherosclerosis include the well-established one-dimensional measurement 
of arterial wall intima-media thickness (IMT) measured using B-mode US and three-dimensional 
(3D) US measurements including total plaque volume (TPV) 4-10 and vessel wall volume (VWV) 6, 
11-19
.  IMT measurements of the common carotid artery are associated with ischemic atherosclerotic 
events 20 and are predictive of ischemic stroke 21, 22. Previous studies have established a relationship 
between intima-media thickness and age 23-25 and this relationship was stronger at the carotid 
bifurcation 24.  Intima-media thickness is typically lower in women and surprisingly, in both sexes, 
carotid IMT is greater in the left carotid artery compared to the right 26-28. 
Recently, the Tromsø study suggested that both age and sex were correlated with carotid 
atherosclerotic plaque and its morphology and that the presence of carotid plaque was a direct 
determinant of cardiovascular events in men 29.  These results underscore the need for a better 
understanding of the relationships between US measurements, age and sex when interpreting 
carotid US results in clinical studies.  While currently it is well-established in healthy adults that 
there is a positive relationship between carotid artery IMT and age/sex 24, 30, 31, there have been no 
3DUS studies that interrogate these relationships.  In previous studies we showed the increased 
sensitivity of 3DUS VWV compared to the gold standard IMT15,16.  However, while we have 
measured 3DUS and B-mode US carotid atherosclerosis measurements in many subjects, we have 
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never evaluated the relationships of these measurements to age or sex. We hypothesized that age 
and sex were also significant determinants of 3DUS vessel wall volume even in subjects with 
underlying atherosclerosis and therefore in this study we evaluated these relationships in a relatively 
large group of patients with diabetes, rheumatoid arthritis or obesity, all of which have been shown 
to share carotid atherosclerosis as a comorbidity. 
 
2.2 Methods 
2.2.1 Study Subjects and Design 
Four different types of study subjects were evaluated and written informed consent was provided 
according to a study protocol approved by a local research ethics board.  Subjects with diabetic 
nephropathy were recruited from nephrology and diabetes clinics at the London Health Sciences 
Centre (London, Canada) and required a diagnosis of type I or type II diabetes mellitus and a 
clinical or histologic diagnosis of diabetic nephropathy, and at least 300 mg/d of urinary albumin 
excretion or 500 mg/d of protein excretion.  Subjects were excluded if they were currently 
undergoing dialysis or had a calculated creatinine clearance lower than 30 mL/min or an 
expectation of mortality or complications during the course of the study. Subjects with mild obesity 
aged 40 to 65 years with body mass index (BMI) ≥ 27 kg/m2 were evaluated with or without type II 
diabetes mellitus or coronary heart disease 16.  Post-kidney transplant patients were evaluated with 
end-stage renal disease that required a primary or secondary renal allograft, a history of diabetes, 
hypertension, ischemic heart disease and previously reported cardiovascular events.  Subjects with 
mild to moderate rheumatoid arthritis were also evaluated with symptomatic joint disease greater 
than three months, swollen joint count ≥ 6 and tender joint count ≥ 8. 
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2.2.2 Image Acquisition Parameters  
High-resolution B-mode images were acquired with an optimized US system for carotid imaging 
(ATL HDI 5000; Philips, Bothel, WA, USA) with a 50 mm L12–5 MHz transducer with a central 
frequency of 8.5 MHz (Philips).  Ultrasound imaging parameters such as gain, time-depth 
compensation and focal points were optimized for each subject by the sonographer, taking into 
consideration the neck size, carotid anatomy and tissue depth penetration required.  3DUS images 
were acquired by freehand scanning along the neck for a distance of approximately 5 cm from 
clavicle to jaw.  Probe orientation and position were tracked with a magnetic tracking system, and 
2-dimensional images were reconstructed into a 3D volume as previously described 32-34. 
 
2.2.3 IMT Segmentation 
For obese subjects, intima-media thickness was measured from longitudinal image planes extracted 
from 3DUS images as previously described 16.  For diabetic, post-transplant and arthritis subjects, 
IMT was measured using B-mode ultrasound imaging from longitudinal frames that were recorded 
on VHS tape or digitally recorded on DVD.  All IMT measurements were generated using Prowin 
24.0 (Medical Technologies International Inc, Palm Desert, CA, USA) for segmentation as 
previously described 35, 36.  To briefly summarize, after calibration, measurements were generated 
from a 10mm segment of the far wall of the common carotid artery, approximately 5 mm distal to 
the carotid bulb.  A different segment was selected for measurement if plaque was identified in that 
location (defined as focal thickening > 1 mm) or if that segment was not included in the 3DUS 
volume.  Between 6 and 12 points were marked along the media-adventitia and the intima-lumen 
boundary with a mouse-driven cursor.  For the measurement of intima-media thickness, the distance 
between the curves defined by the points was generated.  Measurements were repeated three times 
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per image side (left (L) and right (R)), and the median value for the L and R common carotid was 
used to generate mean IMT for each subject. 
 
2.2.4 3DUS Total Plaque Volume Segmentation 
Total plaque volume (TPV) was measured using a semi-automated approach as described elsewhere 
37
.  Briefly, in the longitudinal 3DUS view, the first of three segmentation boundaries was 
segmented at the approximate centre of the plaque. The first segmentation boundary was used to 
identify the end points of the plaque in the longitudinal view.  In the axial view the observer 
segmented an additional two boundaries which were used to estimate plaque morphology.  The end 
points were then interpolated to anchor points on the axial segmented boundaries to generate 
several surface areas used to compute the enclosed volume.  The volume for all individual 
atherosclerotic plaques was summed for each of the L and R carotids and the mean of L and R was 
used to generate mean TPV for each subject. 
 
2.2.5 3DUS VWV Segmentation 
Five observers blinded to subject identity and clinical parameters analyzed all images and 
performed 3DUS vessel wall volume manual 38 or semi-automated segmentation 19.  All observers 
were trained and deemed to be functionally equivalent following a variability trial prior to analysis 
of subject data.  Four observers manually segmented VWV for diabetic, rheumatoid arthritis and 
obese subjects, while a different single observer performed semi-automated segmentation 19 of 
VWV for post-transplant subjects. While the interobserver variability of this algorithm has not been 
studied, only one observer used the algorithm to generate VWV measurements in one of the 
population groups.  However, Ukwatta et al.  have shown, using the same observer, that the 
intraobserver variability of the semi-automated measurement was low at 5.1% compared to 3.9% 
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with the manual measurement (not statistically significantly different) and the accuracy of the 
measurement was quite high, yielding a dice coefficient of 95.4% ± 1.6% for the media-adventitia 
boundary and 93.1% ± 3.1% for the lumen-intima boundary.  Briefly, lumen-intima and media-
adventitia boundaries of the carotid artery were segmented and the area enclosed by each 
segmented boundary was multiplied by the interslice distance, and all areas were summed to obtain 
the final volume of the lumen and vessel wall.  3DUS VWV was generated as the difference 
between the volume enclosed by the arterial wall and the volume of the lumen.  For each subject, L 
and R carotid vessel wall volume was averaged to generate a mean VWV. 
 
2.2.6 Statistical Analysis 
Statistical analyses were performed using IBM SPSS Statistics v. 19 (SPSS Inc, Chicago, Ill, USA).  
The relationship between ultrasound measurements, age and sex was reported with Pearson’s r 
statistic.  Linear regression was performed with GraphPad Prism version 4.01 for Windows 
(GraphPad Software, La Jolla, CA, USA).  Fisher Z transformations were applied to Pearson r-
values to compare correlations.  One-way analysis of variance (ANOVA) was used to compare 
mean values between subject groups.  In all statistical analyses, results were considered significant 
when the probability of making a Type I error was less than 5% (p < 0.05). 
 
2.3 Results  
2.3.1 Subject Characteristics 
Subjects scanned were included in analysis if age and gender were recorded or could be obtained 
from patients who were not lost to follow-up and images were of sufficient quality for the 
measurement of IMT, TPV and VWV.  For the obese subjects, of 175 patients scanned, 35 were 
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excluded due to poor image quality, for diabetics,  12 of 77 scanned were excluded due to poor 
image quality, for the post-transplant subjects, age was not recorded for 8 patients and they were 
unfortunately lost to follow-up and hence no date of birth could be recorded; for RA subjects, 6 
subjects did not have suitable image quality for analysis.   
 
Table 2-1. Study Subject Demographics and Imaging measurements. 
 All 
All  
Males 
All 
Females 
 
Obese 
 
Diabetic 
Post-
transplant 
Rheumatoid 
Arthritis 
n 316 236 80 140 65 83 28 
 
 
  
    
Age yr 
Mean (SD) 55 (9) 55 (9) 57 (9) 51(6) 60 (11) 57 (10) 59 (10) 
 
       
Male Sex 
n (%) 236 (75) -- -- 123 (88) 47 (72) 62 (75) 4 (14) 
        
IMT mm 
Mean (SD) 0.87(0.23) 0.90 (0.24) 0.76(0.17) 0.94 (0.26) 0.87 (0.23) 0.78 (0.17) 0.75 (0.13) 
        
VWV mm3 
Mean (SD) 486 (144) 514 (141) 403 (120) 471 (128) 560 (144) 495 (144) 362 (121) 
 
Subject demographics are provided in Table 2-1 for 316 subjects evaluated (mean age 55 ± 9 years, 
75% male) as well as subjects by sex and subgroup: diabetic nephropathy (n=65), obesity (n=140), 
renal transplant (n=83) and rheumatoid arthritis (n=28).  Subjects from each patient group were 
excluded if age, or intima-media thickness and vessel wall volume measurements were not 
obtainable. Figure 2-1 shows the frequency distribution for variables evaluated in primary 
comparisons.  
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Figure 2-1.  Frequency distribution of age, intima-media thickness and vessel wall volume by 
sex. 
 
2.3.2 Imaging Measurements  
Figure 2-2 shows carotid ultrasound images for a younger male (40 yr) and an older male (70 yr) 
subject.  In Table 2-1, mean carotid intima-media thickness and vessel wall volume are provided for 
all subjects.   
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Figure 2-2.  Representative imaging and carotid ultrasound measurements at different ages.  
Intima-media Thickness is shown on the left and Vessel Wall Volume on the right for a young male 
(40yrs) and an older male (70yrs).  The red line in Intima-media Thickness measurement images 
represents 10 mm.  In Vessel Wall Volume measurements the red represent a cross-section of 
contours that outline lumen-intima boundaries in the common carotid artery while blue contours 
show media-adventitia boundary.  The yellow lines represent contours that identify the lumen-
intima boundary in the internal carotid artery and the green represents contours that show the 
media-adventitia boundary of the internal carotid artery. The interslice distance between contours is 
1 mm. 
 
A one way ANOVA was used to determine statistical significance for differences in age, IMT and 
VWV for each subject group as well as males and females.  All comparisons are summarized in 
Figure 2-3.  As previously described, mean IMT and VWV were significantly higher in males.  
Mean age for obese subjects (51 ± 6 yrs) was significantly lower than in post-transplant (57 ± 10 
yrs), diabetic (60 ± 11 yrs) and rheumatoid arthritis subjects (59 ± 10 yrs).  Mean IMT for obese 
subjects (0.94 ± 0.26 mm) was significantly higher than post-transplant (0.78 ± 0.17 mm) and 
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rheumatoid arthritis subjects (0.75 ± 0.13 mm).  Mean VWV in diabetics (560 ± 144 mm3) was 
higher than in obese (471 ± 128 mm3), post-transplant (495 ± 144 mm3) and rheumatoid arthritis 
subjects (362 ± 121 mm3). 
 
 
 
 
 
 
 
Figure 2-3.  Mean values for age, IMT and VWV by 
subject group.  Mean age (top), intima-media thickness 
(middle) and vessel wall volume (bottom) are plotted for 
all males, all females, post-transplant (PT), obese (OB), 
diabetic (DB) and rheumatoid arthritis (RA) subject 
groups.  Mean values were compared with a one-way 
ANOVA and statistically significant differences are 
denoted by * (p< 0.05). 
 
 
 
 
 
 
2.3.3 Relationship of IMT and VWV with Age and Sex 
In Figure 2-4, the significant relationships are shown for intima-media thickness (r = 0.18, p = 
0.001) and vessel-wall volume (r = 0.24, p < 0.01) with age.  In males alone, IMT (r = 0.19, p = 
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0.003) was also significantly correlated with age as was VWV (r = 0.34, p < 0.0001).  In females, 
IMT and age were significantly correlated (r = 0.30, p = 0.007), but VWV and age were not (r = 
0.10, p = 0.4).  In addition, there was no significant relationship (r = 0.15, p = 0.186) between age 
and TPV in females.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-4.  Relationship between 3D ultrasound measurements of carotid atherosclerosis and 
age.  Intima-media Thickness and age (left) for obese, diabetic, transplant and arthritis populations 
grouped and Vessel Wall Volume and age comparisons (right). Relationships also presented by sex 
(middle and bottom). 
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In Table 2-2, the Pearson r values for IMT and VWV and age are provided.  The transformed Fisher 
Z values were not significantly different indicating that the relationships between IMT and VWV 
with age were not different. 
 
Table 2-2.  Pearson -Product-Moment correlations between IMT, VWV and age. 
 All Male Female 
IMT mm    
r (p-value) 0.18 (0.0012) 0.19 (0.0028) 0.30 (0.0071) 
R2 0.03(0.0012) 0.04 (0.0028) 0.09 (0.0071) 
    
VWV mm3    
r (p-value) 0.24 (0.0001) 0.34 (0.0001) 0.10 (0.37) 
R2 0.06 (0.0001) 0.12 (0.0001) 0.01 (0.37) 
    
TPV mm3    
r (p-value) ND ND 0.15 (0.19) 
R2   0.02 (0.19) 
 
The results of simple linear regressions are provided in Figure 2-4 and these were used to determine 
the change over time (slope) for IMT and VWV.  In all subjects, mean IMT increased by 0.005 
mm/yr (p = 0.001), while VWV increased 4 mm3/yr (p < 0.01).  In males, these values were similar 
(IMT = 0.005 mm/yr (p = 0.003); VWV=5 mm3/yr (p < 0.0001)).  In females, IMT increased 0.006 
mm/yr (p = 0.007) and there was no relationship between age and VWV in females. 
The relationships between intima-media thickness, vessel wall volume and total plaque volume are 
shown in Figure 2-5.  For males and females together (Figure 2-5, top L panel), the association 
between IMT and VWV was significant (r = 0.55, p <0.0001), and in females alone (Figure 2-5, 
bottom left) there was also a significant and positive correlation between IMT and VWV (r = 0.37, 
p = 0.001).  However, while in females VWV and TPV showed a significant relationship (r = 0.36, 
p = 0.001) (top right panel Figure 2-5), there was no significant relationship between IMT and TPV 
(r = 0.11, p = 0.34) (bottom right). 
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Figure 2-5.  Correlations between ultrasound measurements.  Comparisons between Intima-
media Thickness and Vessel Wall Volume (left) are shown for all subjects (top-left) and female 
subjects only (bottom-left). Correlations between Intima-media Thickness, Vessel Wall Volume 
and Total Plaque Volume in females are shown (right). 
 
2.4 Discussion 
We made a number of observations in a relatively large group of subjects with a variety of diseases 
as follows: 1) in all subjects, IMT correlated with VWV, and in females alone, VWV correlated 
with TPV, but TPV did not significantly correlate with IMT, 2) in all subjects and in males 
evaluated alone, IMT and 3DUS VWV were significantly associated with age, 3) in females alone, 
IMT was positively and significantly correlated with age, but 3DUS VWV and TPV were not.  It 
has been well established for the ultrasound measurement of intima-media thickness that there is a 
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positive relationship with age.  In other words, carotid IMT naturally increases over time by 
fractions of a mm even in subjects without underlying disease or atherosclerosis.  In subjects 
without atherosclerotic plaque, 3DUS vessel wall volume is essentially a 3D IMT measurement and 
in those subjects with plaque, 3DUS VWV consists of both atherosclerotic plaque and arterial wall 
intima-media layers.  We hypothesized that VWV and IMT would share a similar relationship with 
age and sex and therefore in this study we explored the relationship between 3DUS carotid 
atherosclerosis VWV with age and sex. 
First, in all subjects we were not surprised to observe that intima-media thickness correlated with 
vessel wall volume, and in females alone, VWV correlated with total plaque volume, but TPV did 
not significantly correlate with IMT.  While intima-media thickness has been used as a clinical 
endpoint for longitudinal studies, the absence of a relationship between TPV and IMT suggests that 
IMT does not provide a good estimate of the presence of plaque.  In this regard, vessel wall volume 
may be of more value as it is a comprehensive measurement that includes a cross-sectional IMT of 
common carotid and internal carotid arteries with plaque volumes. Polak et al. have identified that 
while intima-media thickness of the CCA and intima-media thickness of the ICA both predict 
cardiovascular events, intima-media thickness of the ICA improves predictive power when 
combined with Framingham risk factors to classify risk for cardiovascular outcomes39.  In healthy 
subjects, vessel wall volume provides a three-dimensional intima-media thickness measurement of 
arterial wall hypertrophy for both CCA and ICA.  Furthermore, elevated VWV may also provide an 
early atherosclerosis measurement. 
Second, we observed a positive and significant correlation between both intima-media thickness 
and vessel wall volume with age in all subjects.  Mean IMT for all subjects in this study was 0.87 ± 
0.23 mm and in a systematic review, Aminbakhsh and Mancini 23 identified an increased risk of 
stroke for IMT values greater than 0.75 mm and increased myocardial infarction risk when IMT 
values were greater than 0.82 mm.  We also observed that mean intima-media thickness was 
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significantly higher in males than females, previously reported in the literature 24.  The population-
based Tromsø study described the relationship of age with cardiovascular disease and reported an 
increased incidence of cardiovascular disease in males with carotid plaque 29.  We observed that 
VWV, essentially a 3D measurement of IMT and plaque, was also correlated with age, but only in 
males. 
Third, we observed that 3DUS VWV was not significantly associated with age in females, although 
the relationship in females between IMT with age was positive.  Because VWV is essentially a 3D 
IMT and plaque measurement, we investigated the role of plaque in this relationship and measured 
total plaque volume in females.  For example, in the Tromsø study it was shown that menopause 
may have had an adverse effect on atherosclerosis characterized by a curvilinear trend between 
aging and plaque prevalence in women 29.  To provide a way to better understand these results, in 
females only we evaluated the relationship of presence and volume of plaque (TPV) with IMT and 
VWV.  We were surprised to see only a modest but significant correlation (r = 0.37, p = 0.0008) 
between IMT and VWV in females, and this association was not unexpected as IMT is essentially a 
component of the VWV measurement.  Differences in relationships with age may be explained by 
the reactive changes in intima-media thickening due to increased blood pressure and shear stress 
resulting from turbulent flow.  In addition intima-media thickness changes during the cardiac cycle, 
whereas cross-sectional area of IMT is thought to be constant 40,41.  Although correlations have 
previously been shown between IMT and the presence of plaques 40, there was no relationship 
between IMT and TPV observed in this study.  We did observe a modest relationship between 
VWV and TPV in this study which was not unexpected because plaque is included in the vessel 
wall volume measurement. 
According to these findings we suggest there may be a clinical impact in interpreting ultrasound 
scanning of the carotid artery.  We hypothesize that plaque development in females may not be 
related to age but may be influenced more by inflammation. Over half of the females included in 
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this analysis were characterized by inflammatory processes such as rheumatoid arthritis and post 
kidney transplantation.  As a result, traditional intima-media thickening may not be a good 
prognostic indicator of cerebrovascular events in females. Three-dimensional ultrasound 
measurements are more sensitive and may also provide a better estimate of risk in females. 
Investigation into the pathophysiology of plaque development and its relationship to carotid 
ultrasound imaging may provide a better understanding of the clinical meaning of ultrasound 
measurements. 
We must also acknowledge a number of study limitations that may limit our conclusions.  For 
example, correlations between age and ultrasound measurements did not control for a number of 
cardiovascular risk factors because these were not available for all subjects.  However, for a large 
subset of the study sample (n=195), smoking history, systolic and diastolic blood pressure, HDL 
cholesterol, LDL cholesterol, total cholesterol and triglycerides were recorded and adjusted for with 
the result being the same positive associations.  Although the relationship between age and intima-
media thickness has been well established in the literature, comparisons of age and 3DUS VWV 
have never before been documented and this was the rationale for the current analysis.  The current 
results certainly motivate further research into determining the relationship between age and 
imaging measurements in those with moderate disease and age-matched healthy subjects without 
co-morbidities.  We also recognize that the small number of females included in this analysis may 
have limited the power to detect differences between the sexes in this study.  Moreover, neither 
menopausal state nor hormone replacement status were reported by our subjects so this information 
could not be used when interpreting our results.  Therefore, these preliminary findings should be 
considered hypothesis-generating for future studies that evaluate the specific relationship between 
age, sex and underlying disease in the generation and progression of carotid atherosclerosis. 
The present study explores the relationship between ultrasound measurements of carotid 
atherosclerosis with age and sex and is the first to describe the relationship between vessel wall 
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volume, total plaque voulme and age.  Our results suggest that age and sex are significant 
determinants of VWV even in subjects with risk factors and underlying atherosclerosis.  Further 
studies are required to identify abnormal vessel wall volume as it relates to age in healthy 
individuals.  We have previously shown VWV is a precise, non-invasive measurement with low 
inter-and intraobserver variability5.  The sensitivity of this measurement allows us to regionally 
evaluate local thickening as temporal changes in VWV can be measured in as little as 12 weeks13.  
Additionally, we have previously demonstrated changes in vessel wall volume in response to 
therapy and dietary intervention 16.  Recently, the VWV measurement has been semi-automated to 
reduce segmentation time increasing its potential for clinical application in monitoring and 
diagnosing atherosclerosis 19.  Further investigation of 3DUS vessel wall volume and its 
relationship to risk factors is required in order to determine its ability to predict cardiovascular 
events and serve as a biomarker in clinical trials. 
 
2.5 Conclusions 
In a large group of subjects with a variety of diseases that include atherosclerosis as a co-morbidity 
we observed that in all subjects intima-media thickness correlated with vessel wall volume but in 
females VWV correlated with total plaque volume, and TPV did not significantly correlate with 
intima-media thickness. Additionally, in all subjects, and in males alone, intima-media thickness 
and 3DUS vessel wall volume were significantly associated with age. In females alone, intima-
media thickness was positively and significantly correlated with age, but 3DUS vessel wall volume 
was not.  Further analysis of plaque revealed that total plaque volume and age were not associated 
in females. 
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Chapter 3: Semi-automated Segmentation of Three-
dimensional Ultrasound Carotid Atherosclerotic Plaque 
Volume 
 
3.1 Introduction 
Atherosclerosis in the carotid arteries manifests as plaque lesions that can lead to ischemic stroke.  
In particular, it is the size, shape and composition of atherosclerotic plaque that are predictive of 
stroke risk 1-4.  In this regard, in addition to monitoring traditional risk factors such as lipid 
biomarkers and blood pressure, carotid imaging methods have also been developed for direct 
measurements of carotid disease5.  In clinical and diagnostic evaluations of carotid atherosclerosis, 
magnetic resonance imaging and x-ray angiography methods may be used6, but Doppler ultrasound 
measurements of carotid flow perturbations dominate because it is fast, portable, relatively 
inexpensive, reliable and noninvasive 7-9. 
For research studies of carotid atherosclerosis, B-mode ultrasound provides a direct, reliable and 
relatively straightforward measurement of carotid intima-media thickness (IMT) and this has been 
widely used and shown to correlate with important clinical outcomes such as stroke and mortality10, 
11
.  Components of the IMT are critical as Finn et al described that common carotid artery (CCA) 
IMT without atherosclerotic plaque is more reflective of hypertensive medial hypertrophy than 
atherosclerosis itself 12 and has been shown to be an indicator of hypertension 13, 14.  Moreover, 
plaque is not often included in the IMT measurement although plaque appears to be a better 
predictor of inflammation than IMT alone 15.  
Independent of IMT, the measurement and monitoring of carotid plaque itself has been shown to be 
important for stroke risk stratification and prognosis 16-18. For example, plaque area and volume 
measured in the internal carotid artery have been shown to be better predictors of inflammatory 
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disease and myocardial infarction 13, 15 compared to IMT.  In fact the Norwegian Tromsø 10-year 
follow up study of ischemic stroke risk suggested that plaque area was a stronger predictor of 
ischemic stroke than IMT19.  Total Plaque Area (TPA) is a 2D estimation of plaque in the 
longitudinal plane8.  While this cross-sectional area provides a rapid estimation of plaque area, 
measurement variability is inherently high because image acquisition depends on repeatedly 
selecting the same representative longitudinal view for each new measurement.  Importantly, while 
TPA  changes approximately 10 mm2/year20 annual IMT changes are approximately half the 
resolution of ultrasound 21, which makes US detection of changes in IMT impossible under normal 
circumstances. 
To address this limitation and others associated with B-mode carotid IMT, three-dimensional 
ultrasound (3DUS) imaging phenotypes have been developed including vessel wall volume22-25, and 
total plaque volume (TPV) 26-32.  3D ultrasound volumetric measurements have been shown to be 
more sensitive to change in the vessel wall as significant changes in arterial wall volume have been 
observed in response to statin therapy and dietary intervention in as little as twelve weeks. Although 
3D measurements such as TPV provide estimates of plaque volume that encompasses the complex 
geometries and morphologies associated with plaque 31, 33 their use is limited to research studies.  
Current manual segmentation of these 3D measurements is laborious and time-intensive limiting 
their potential for wide application in the clinical setting. 
While TPA (measured in the longitudinal view) and manual TPV (measured in the axial view) are 
measured in a single plane only, our aim was to generate a method that incorporated information 
from both the longitudinal and axial views, maximizing the use of the 3DUS information to 
approximate TPV.  In other words, we aimed to incorporate the longitudinal view - ideal for rapidly 
identifying the ends of a plaque, and the cross-sectional axial view measurements – ideal for 
providing information on plaque morphology in our semi-automated approach.  Unfortunately there 
is currently no clinically acceptable tool that is capable of generating reproducible, direct 
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measurements of plaque alone.  Accordingly, our objective was to generate a semi-automated 
approach quantifying plaque volume to enable real-time bedside measurement requiring reduced 
segmentation time and complexity in decision making.  
 
3.2 Methods 
3.2.1 Study Images 
Carotid plaque lesions were analysed from 3DUS carotid images acquired in subjects with 
asymptomatic carotid stenosis greater than 60% as determined by carotid Doppler ultrasound and 
recruited from The Premature Atherosclerosis Clinic (London, Ontario, Canada) or from those who 
had consented to participation in the Dietary Intervention to Reverse Atherosclerosis Trial with 
body mass index (BMI) ≥27 kg/m2 as previously described18, 34.  Each study protocol was approved 
by a local research ethics boards and all subjects provided written informed consent. 
 
3.2.2 Image Acquisition 
To acquire 3DUS images, an ultrasound probe (L12-5, 50 mm, Philips, Bothell, WA, USA) was 
translated along the subjects’ neck at 3mm/s using a mechanical device that guided the transducer 
along a fixed path and at uniform speed.  2D frames were acquired from the ultrasound system 
(ATL HDI 5000, Philips) in an axial direction for 4 cm of the neck.  An 8.5MHz transducer 
captured several parallel 2D frames separated by 0.15 mm, which were digitized and saved.  The 
image frames were reconstructed into a 3D image based on weighted pixel intensities values using a 
3D Echotech system (GE Medical Systems, Milwaukee, Wis).  Ultrasound parameters were 
optimized for each patient scanned. 
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3.2.3 Image Analysis 
In total 23 different carotid plaque lesions were selected for analysis to represent a range of plaque 
sizes and volumes within close proximity to the carotid bifurcation -5 mm into the internal carotid 
artery and 25 mm into the common carotid artery from the flow divider.  Two observers measured 
all 23 plaques once using manual planimetry and using semi-automated segmentation on multiple 
occasions.   
To evaluate repeated measurements made within a single three-to-five minute period – referred to 
in this work as 5 minute repetitions - five consecutive semi-automated segmentation measurements 
were made for each plaque by both observers with observers blinded to subject clinical status.  To 
evaluate repeated measurements made within a week, both observers also completed repeated 
measurements of each plaque five times over a 5 day period with a 20 hour gap – referred to as 20 
hour repetitions - between measurement sessions.  As previously described, we defined TPV as the 
sum of all plaque volumes within a single subject including both common and internal carotid 
arteries. Typically, left and right sides were summed to generate a cumulative TPV for each subject.  
However, for the analysis presented here, each individual plaque was evaluated independently for 
comparison of manual and semi-automated methods. 
 
3.2.4 Manual Segmentation 
Methods previously described were employed for the manual measurement of carotid plaque 
volume 33.  Briefly, the user identified the bifurcation of the common carotid artery and selected a 
parallel axis for segmentation.  An Intuos3 professional pen tablet (Wacom Technology 
Corporation, Vancouver, WA, USA) was used to manually segment plaque boundaries.  
Initialization of the measurement occurred in the axial plane whereby the beginning of the plaque 
was identified and a contour was drawn to generate a cross-sectional area.  Plaque segmentation 
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along the parallel axis at 1mm interslice distances was performed until the entire plaque was 
measured. Cross-sectional areas were multiplied by the inter-slice distance to compute a volume.   
 
3.2.5 Semi-Automated Segmentation Methodology 
The algorithm that we developed to measure TPV semi-automatically takes advantage of the fact 
that in a 3DUS volume, both the longitudinal and axial views provide a way to estimate the ends of 
each plaque and the morphology across each individual plaque.   
The first step involved the observer using the 3DUS volume in the longitudinal and axial planes to 
identify the estimated ends of a single plaque visibly obvious as echogenic plaque.  The second step 
involved identification of the estimated midpoint of the plaque in the longitudinal plane and a 
contour generated from this midpoint (Contour 1, C1).  From C1, the minimum and maximum 
values along the z-axis were identified by the algorithm as the end points of the plaque.  To assist 
with geometric approximation of the entire plaque volume, three additional boundaries in the 
longitudinal view were generated by the user (Contour 2, C2; Contour 3, C3 and Contour 4, C4).  
Finally, the maximum and minimum z values (end points) were automatically joined to 20 points 
along C2 and C4.  Additionally, the same number of points on C3 was connected to points on C2 
and C4.  Figure 3-1 shows contours from the view of the sonographer (top row) and an algorithm 
schematic view of contour placement within the plaque (bottom row) used to estimate plaque 
volume. 
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Figure 3-1.  Observer input for semi-automated TPV measurement.  In the longitudinal view 
(and with assistance from the axial view, not shown) the user identifies the maximum and minimum 
z-values representing the end points of the plaque (Min Z and Max Z).  The user identifies the 
longitudinal mid-point of the plaque (C1) and finally C2, C3, andC4 are identified and generated.  
Uniform plaque geometry between C2 and C3 as well as C3 and C4 is assumed and a final volume 
is generated. 
  
The points along C2, C3 and C4 were linearly interpolated to generate triangular surface areas.  The 
resulting geometric approximation was a polyhedron with several surface areas (Ai) where m faces 
(Fj) labelled F0,…Fm-1 were used to compute a volume 35 as shown in equation 1 below.  
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From a single face of the enclosed volume, the surface area is multiplied by a height, which was 
established by isolating the y-component of a vector that extended from the surface of the face to a 
representative vertex within the volume as shown in Figure 3-2. 
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Figure 3-2.  Geometric approximation for semi-automated TPV measurement.  From the 
observer input, several triangular surface areas are generated to approximate the enclosed volume. 
  
For semi-automated segmentation, prior to establishing segmentation boundaries the observer 
identified the bifurcation and set a parallel axis for segmentation.  Plaque boundaries were defined 
as a distinct increase in wall thickening in comparison to neighbouring wall accompanied with 
hyperechoic signal.  From the marked bifurcation, a point was placed 10 mm into the common 
carotid artery in the center of the lumen.  A second point was placed 5 mm in the center of the 
lumen of the internal carotid artery.  The longitudinal plane was manipulated until both points were 
in view creating an axis along the artery from the common carotid to the internal carotid artery.  
After establishing an axis of segmentation, a two-plane approach was used to estimate plaque 
volume as described in Figure 3-3.   
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Figure 3-3. Semi-automated total plaque volume measurement pipeline. 
3.2.6 Statistical Analysis 
Intra-observer variability was assessed using the intra-class correlation coefficient (ICC) for both 
five repetitions within 5 minutes and five repetitions separated by 20 hours to assess the intra- and 
inter- reliability.  Coefficient of variation (standard deviation of five independent measurements 
divided by the mean) for each plaque was also calculated for all five repeated semi-automated 
measurements.  Semi-automated measurements were compared to manual segmentations using 
linear regression, Pearson correlation coefficient and Bland Altman plots.   Linear regression was 
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performed with GraphPad Prism version 4.01 for Windows (GraphPad Software, La Jolla, CA, 
USA).  Additionally the ICC was used to identify the intra – and inter-observer variability between 
observers. A repeated measures ANOVA was performed to compare repeated plaque volume 
measurements. Statistical analyses such as paired t-tests and ANOVA were performed using IBM 
SPSS Statistics v. 19 (SPSS Inc, Chicago, Ill, USA).  In all statistical analyses, results were 
considered significant when the probability of making a Type I error was less than 5% (p < 0.05).  
 
3.3 Results 
Each observer completed five consecutive repetitions to yield a mean plaque volume for all 23 
plaques.  The mean plaque volume measurements for each observer are reported in Table 1.  
Repeated measurements were made same-day within 5 minutes of each other and generated a semi-
automated mean plaque volume of 92.5 ± 8.9 mm3 for Observer 1 while the mean plaque volume 
was 82.8 ± 8.3 mm3 for Observer 2.  Plaque volume measurements were also performed five times 
with 20 hours separating repetitions.  Mean semi-automated plaque volume for Observer 1 for 20 
hour measurements was 92.7 ± 11.8 mm3 and 83.1 ± 7.8 mm3 for Observer 2.  Measurements from 
both observers for 5 minutes and 20 hour repetitions were grouped and a paired samples t-test 
indicated no significant difference between measurements (p = 0.766).  Plaque volume 
measurementsbetween observers were also not significantly different (p = 0.355). 
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Table 1. Mean semi-automated plaque volumes and intra-observer comparisons. Intra-
observer variability reported by coefficient of variation. 
 
 
Manual measurements for all 23 plaques were completed once by both observers.  Manual plaque 
volume measurements were not significantly different (  = 107.6 mm3) for Observer 1 when 
compared to mean 5 minute repetitions (p = 0.603) and mean plaque volume for 20 hour repetitions 
(p = 0.608).  Similar analyses were also performed for Observer 2 comparing the mean of the 
manual measurement round (  = 99.0 mm3) to mean semi-automated plaque volumes 
measurements for 5 minute (p = 0.497) and 20 hour (p = 0.503) repetitions.  Figure 3-4 shows semi-
automated measurements and manual segmentation boundaries for a plaque < 100 mm3 (top) and > 
100 mm3 (bottom). 
Observer 1 Observer 2 
5 Minutes 20 hours 5 Minutes 20 hours 
Plaque 
ID 
SA PV 
(  ±SD  
in mm3) 
CV 
(%) 
SA PV 
(  ±SD 
 in mm3) 
CV 
(%) 
SA PV 
(  ±SD  
in mm3) 
CV 
(%) 
SA PV 
(  ±SD  
in mm3) 
CV 
(%) 
1-1 89.6 ± 10.4 11.6 77.9 ± 4.0 5.1 87.9 ± 2.4 2.7 89.0 ± 3.4 3.8 
2-1 26.3 ± 1.8 6.9 23.2 ± 1.2 5.3 13.5 ± 1.7 12.3 14.6 ± 1.0 6.6 
2-2 39.9 ± 3.6 9.1 44.1 ± 4.3 9.7 30.1 ± 1.9 6.2 30.9 ± 2.9 9.5 
3-1 283.7 ± 18.1 6.4 272.3 ± 15.8 5.8 256.6 ± 19.0 7.4 253.3 ± 16.2 6.4 
4-1 147.6 ± 1.1 0.7 145.3 ± 10.5 7.3 109.5 ± 9.0 8.3 111.9 ± 13.7 12.3 
7-1 58.0 ± 2.9 5.1 53.5 ± 5.6 10.5 48.8 ± 3.3 6.7 51.7 ± 3.3 6.5 
7-2 95.3 ± 5.0 5.3 97.1 ± 6.2 6.4 74.6 ± 6.1 8.1 75.3 ± 6.0 7.9 
8-1 26.3 ± 2.1 8.1 26.5 ± 2.3 8.5 41.6 ± 3.1 7.4 46.1 ± 3.3 7.2 
8-2 61.8 ± 4.9 7.9 66.1 ± 9.7 14.6 81.2 ± 7.2 8.9 83.1 ± 8.6 10.4 
10-1 165.2 ± 7.8 4.7 167.0 ± 8.8 5.3 118.1 ± 11.0 9.3 116.3 ± 8.5 7.3 
11-1 54.7 ± 2.9 5.3 65.2 ± 8.5 13.1 72.0 ± 5.3 7.3 74.6 ± 4.2 5.6 
12-1 16.8 ± 1.0 6.1 19.0 ± 1.3 6.8 23.6 ± 1.2 5.2 26.6 ± 1.9 7.0 
14-1 76.1 ± 4.2 5.5 75.5 ± 5.5 7.3 123.8 ± 16.0 13.0 100.5 ± 6.0 6.0 
15-1 21.3 ± 2.5 11.7 22.4 ± 2.8 12.3 31.7 ± 3.1 9.9 29.2 ± 2.8 9.5 
19-1 85.4 ± 9.2 10.7 85.1 ± 3.2 3.7 39.7 ± 3.5 8.9 37.3 ± 2.6 6.9 
22-2 13.4 ± 0.8 5.6 12.8 ± 0.7 5.3 10.7 ± 0.7 6.7 11.0 ± 1.3 12.2 
22-3 35.3 ± 1.0 2.7 36.2 ± 2.7 7.4 32.1 ± 3.3 10.1 33.0 ± 3.2 9.6 
23-1 287.1 ± 18.8 6.5 294.6 ± 34.4 11.7 190.7 ± 12.4 6.5 206.5 ± 13.1 6.4 
24-1 280.2 ± 22.4 8.0 276.3 ± 27.7 10.0 239.5 ± 14.8 6.2 249.3 ± 18.7 7.5 
25-1 138.5 ± 8.5 6.1 159.1 ± 17.2 10.8 201.6 ± 13.6 6.7 180.9 ± 9.8 5.4 
25-2 28.4 ± 2.8 9.9 27.2 ± 4.1 15.0 21.2 ± 2.0 9.5 23.2 ± 2.9 12.4 
27-1 30.5 ± 3.4 11.3 28.8 ± 4.9 17.0 18.4 ± 1.8 9.9 21.4 ± 2.6 12.3 
27-2 66.3 ± 12.6 18.9 56.9 ± 10.7 18.7 37.5 ± 2.4 6.4 45.8 ± 4.3 9.3 
Mean 92.5 ± 8.9 9.6 92.7 ± 11.8 12.7 82.8 ± 8.3 10.0 83.1 ± 7.8 9.4 
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Figure 3-4. Representative manual and semi-automated segmentation boundaries. Semi-
automated measurements (blue) and manual segmentation boundaries (red) in axial (left) and 
longitudinal (right) views for a plaque < 100 mm3 (top) and > 100 mm3 (bottom). 
Yellow bar represents 10mm. 
 
Coefficient of variation was calculated for each plaque at both time spans and for both observers 
and is reported in Table 1 along with mean volume measurements for each plaque.  Intra-observer 
variability for 5 minute repetitions was reported with a CV of 9.6% for Observer 1 and 10% for 
Observer 2.  Coefficient of variation for 20 hour repeated measurements was 12.7% for Observer 1 
and 9.4% for Observer 2.  The relationship between coefficient of variation and the mean semi-
automated plaque volume is shown in Figure 3-5 for each measurement time span.  
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Figure 3-5.  Relationship of semi-automated plaque volume and variability of measurement 
(CV).  Intra-observer variability is represented by the coefficient of variation (CV) for 5 minute 
repeated measurements (triangle) and measurements separated by 20 hours (circle) plotted against 
mean semi-automated plaque volume (SA PV) for Observer 1 (left) and Observer 2 (right). 
 
Five minute measurement repetitions were compared using a repeated measures ANOVA and were 
not significantly different for Observer 1 (p = 0.68, sphericity assumed).  However, for Observer 2 
repetitions separated by 5 minutes were statistically significant after correcting for violations of 
sphericity (p = 0.042, Green-house Geisser correction). Measurement rounds were not significantly 
different at 20 hour time-gaps for either Observer 1 (p = 0.120, Green-house Geisser correction) or 
Observer 2 (p = 0.053, Green-house Geisser correction).   
The intraclass correlation coefficient for absolute agreement was significant (p < 0.001) for 5 
minute repeated measurements (ICC = 0.990) and 20 hour repeated measures (ICC = 0.982) for 
Observer 1.  Observer 2 also demonstrated significant correlations for 5 minute (ICC = 0.988) and 
20 hour (ICC = 0.989) time spans.  The ICC was also utilized to analyze the inter-observer 
variability between observers for different measurement time spans.  Observer measurements were 
strongly significantly correlated for 5 minute (ICC = 0.911) and 20 hour time-gaps (ICC = 0.940).   
Semi-automated measurements were compared with the reference standard, manual planimetry.  
Mean semi-automated plaque measurements were highly correlated with manual measurements for 
both 5 minute measures in both Observer 1 (r2 = 0.96, p < 0.001) and Observer 2 (r2 = 0.97, p < 
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0.001) and similarly for 20 hour measures in Observer 1 (r2 = 0.97, p < 0.001) and Observer 2 (r2 = 
0.99, p < 0.001). Results from linear regression analysis are shown in Figure 3-6.  
 
Figure 3-6. Linear regression analysis for manual and semi-automated plaque measurements.  
Semi-automated plaque volume (SA PV) plotted against manual plaque volume (PV) for Observer 
1 (left) and Observer 2 (right) 5 minute repeated measurements (top) and measurements separated 
by 20 hours (bottom).  Dotted lines represent 95% confidence interval. 
 
Bland Altman plots show high agreement between measurements methods as indicated by the 
confidence limits shown in Figure 3-7.  The bias for Observer 1 for 5 minute measurements was -
15.11 mm3 while the 20 hour repeated measures bias was -14.91 mm3.  Observer 2 also 
demonstrated a negative bias of -16.23 mm3 for 5 minute repeated measurements and -15.93 mm3 
for 20 hour repeated measures.   
65 
 
 
 
Figure 3-7.  Bland Altman analysis of agreement between semi-automated and manual 
measurement methods.  Absolute difference between mean semi-automated total plaque volume 
(SA TPV) and manual total plaque volume (M TPV) plotted against the mean of manual and the 
mean semi-automated plaque volumes.  Analysis for Observer 1 (left) and Observer 2 (right) 5 
minute repeated measurements (top) and measurements separated by 20 hours (bottom).  Limit of 
agreement is indicated by the dotted lines representing 95% level of confidence.  
 
3.4 Discussion 
We have validated a novel semi-automated approach for measurement of total plaque volume and 
made two central observations: 1) we have demonstrated the semi-automated plaque volume 
measurement is reproducible; 2) there is considerably high accuracy between manual planimetry 
and semi-automated total plaque volume measurements.  Total plaque volume has been correlated 
to cardiovascular events such as stroke20.  Measurement of plaque size is important in quantifying 
risk for stroke and determining treatment36.  3D ultrasound plaque volume measurements have 
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shown significant changes in response to statin therapy18.  However, plaque volume estimation 
using 3DUS has been limited in the past due to long measurement times and specialized training.  
We hypothesized that faster semi-automated measurements would share similar intra- and inter-
observer variability and accuracy to established manual methods.   
The intra-observer variability of both observers was analyzed for measurements completed within 5 
minutes.  Highly correlated ICC values and low coefficient of variation values indicate low 
variability.  Coefficient of variation decreased with increasing plaque volume for both 5 minute and 
20 hour measurements, which has been previously reported31.  Manual plaque volume 
measurements have been reported by Landry et al.31 and thus were not repeated here.  From this 
previous work the relationship between manual plaque volume measurements and CV was 
interpolated using the mean of our manual measurements.  For a mean of approximately 100 mm3, 
Landry et al. report a manual CV of 10% which is similar to the values we have reported for semi-
automated measurements.  Additionally, the reproducibility was high between observers as reported 
by high ICC values indicating that observers are functionally equivalent.  Semi-automated plaque 
volume estimates separated by 20 hours did not produce statistical differences suggesting that time 
between measurements did not affect variability. 
Secondly, the accuracy of semi-automated measurements was determined using manual 
measurements as a reference standard.  Manual planemitry and semi-automated measures were 
significant and highly correlated.  In line with results of the linear regression analysis, Bland 
Altman plots indicated high agreement between the two methods as data comparing absolute 
differences between methods to the average of both methods were within confidence limits.  
However, the semi-automated measurement was biased in that it underestimated manual 
measurements.  The margin of underestimation was similar for 5 minute and 20 hour repetitions.  
This underestimation bias could be eliminated by performing longitudinal comparisons.  Change in 
plaque would not be influenced by the bias as it remains consistent between time points. 
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While the semi-automated measurement can be made in just over a minute, we acknowledge there 
are certain limitations that may affect the utility of this measurement.  Manual planimetry 
measurements were used as the reference standard however these measurements have yet to be 
validated with histology.  Future validation of plaque histology to 3DUS imaging is essential in 
ensuring imaging measurements accurately estimate true changes in plaque size.  Additionally, the 
semi-automated plaque volume algorithm uses a geometric approach to quantify plaque size and 
does not incorporate image information such as global or local region boundary analysis and pixel 
intensity information.  A semi-automated geometric approach does however offer certain benefits 
over automated methods in that the observer can compensate for shadowing and other artefacts 
from surrounding structures.  Finally, although the first set of measurements for the 20 hour data set 
was acquired from the first round of the 5 minute dataset, after excluding these rounds in grouped 
measurement comparisons from both observers the significance of the paired samples t-test did not 
change (p = 0.766) when comparing 5 minutes and 20 hour repetitions. 
In conclusion, we have developed a geometrically based semi-automated total plaque volume 
segmentation measurement that is reproducible and accurate while reducing measurement time.  
Repeated measurements at 5 minute and 20 hour time gaps have demonstrated low variability 
within and between observers.  Estimation of plaque with semi-automated methods is highly 
correlated with manual measurements providing accurate estimates when compared to manual 
measurements.  This method has clinical potential for the estimation of plaque burden and could 
play an important role in monitoring of plaque progression and regression over time. 
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Chapter 4: Conclusions and Future Work 
4.1 Summary 
Current clinical tools and measurements that are used to evaluate and characterize coronary and 
carotid atherosclerosis are limited in their ability to provide rapid and direct measurements of 
atherosclerotic plaque.  In other words, while a number of indirect biomarkers have been developed 
as surrogate measurements of plaque,1-4 carotid artery imaging is the only way to provide direct in 
vivo and non-invasive or minimally invasive measurements of atherosclerosis.   
In this regard, carotid ultrasound imaging has been developed to provide 1D, 2D and 3D 
measurements of arterial wall and plaque5-7 as well as compositional imaging.8, 9  Most commonly, 
carotid atherosclerosis has been characterized using Doppler ultrasound measurements of flow and 
stenosis and B-mode ultrasound measurements of the common carotid artery intima media 
thickness (IMT) which has been correlated with adverse CV events10.  Although B-mode US IMT 
alone does not include a measurement of plaque, 3DUS measurements can provide more sensitive 
measurements of wall thickening than IMT and offer direct estimates of plaque area and volume6, 7, 
11-14
.  3DUS image acquisition is safe, inexpensive and fast15, however 3DUS image measurements 
are limited due to time consuming manual image analyses.  In addition, the true clinical meaning of 
3DUS carotid imaging measurements has not yet been established in cross-sectional or longitudinal 
outcome studies. 
Therefore, the overarching aim of this thesis was to extend the previous work of our team to 
develop a more automated 3DUS carotid atherosclerosis measurement method and a better 
understanding of cross-sectional 3DUS measurements of carotid atherosclerosis in vulnerable 
populations.  The aims of this thesis were to: 1) generate a better understanding of the clinical 
meaning of 3DUS carotid atherosclerosis and show how these measurements relate to traditional 
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risk factors of atherosclerosis 2) to identify their relationship with established imaging phenotypes 
and 3) to increase the clinical and research utility of 3DUS total plaque volume measurements by 
automating its measurement for use at the bedside in real-time. 
The primary objective of this thesis was to establish the relationship between 3D ultrasound 
measurements and traditional risk factors for stroke.  We hypothesized that we would observe a 
similar relationship of VWV with age and sex as observed with carotid IMT.  Chapter 2 provided 
the results of the analysis of the relationship between ultrasound measurements of B-mode US IMT, 
and 3DUS VWV and TPV with age and sex in over 300 subjects with mild to moderate 
atherosclerosis.  This was the largest 3DUS atherosclerosis imaging retrospective analysis 
accomplished to date incorporating subject populations with stroke co-morbidities such as diabetes, 
obesity, arthritis and post-surgical intervention.  In this analysis we showed a significant correlation 
of IMT with age, for all subjects and both sexes which is a finding that has been reported in the 
past.16-18  While in all subjects and in males only 3DUS VWV correlated with age, in females we 
observed that although IMT was significantly associated with age, VWV was not.  Since VWV is 
essentially 3D IMT+TPV, the relationship between age and TPV was also analyzed in females.  
The relationship between age and TPV was not significant.  Due to the large role of inflammation in 
the co-morbidities included in our analysis we suggested that plaque development in females may 
be dependent on inflammation and not age. 
The secondary objective of this thesis was to develop and test a semi-automated measurement of 
carotid TPV measurements to improve the utility of TPV as a surrogate for carotid artery disease.  
Chapter 3 outlined the development and application of a semi-automated TPV measurement and 
extends our preliminary results submitted and accepted for presentation and publication (see 
Appendix B).  Motivating this development was the fact that manual 3DUS measurements of TPV 
can require up to 1 hour of image analysis per image and this has certainly limited translation to 
large-scale clinical trials and real-time patient monitoring in the clinic.  For example, the 
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identification of vessel wall boundaries, establishing segmentation axes, determining plaque 
boundaries, distinguishing artefacts and interpreting slice-specific boundaries all contribute to 
increased measurement times.  Automating aspects of this  measurement should reduce the time 
required for image analysis and allow for real-time bedside measurements.  To address this 
problem, we generated a way to approximate TPV and evaluated variability using images from 
subjects with severe atherosclerosis and stenosis >60%.  We showed low variability as reported 
with low coefficient of variation and high intraclass correlation coefficients for intra- and inter-
observer variability.  Additionally, Bland Altman and linear regression analysis reported high 
agreement between manual and semi-automated measurement methods.  Our analyses also revealed 
an underestimation bias in semi-automated measurements. 
 
4.2 Limitations of Current Work and Unanswered Questions 
We identified a number of limitations in our development of semi-automated segmentation of TPV 
and as well in exploring the relationship of VWV with age and sex. 
In Chapter 2, while ultrasound measurements were compared with each other and to age and sex, 
the association of these measures in relation to other cardiovascular risk factors could not be 
determined in our study.  Additionally, the effect of endogenous hormones or hormone replacement 
therapy could not be accounted for in our analysis.  Our database was created following the 
acquisition of images for each population group and as such data for other biomarkers was not 
consistently acquired from each group.  Subjects scanned were included in analysis if age and 
gender were recorded or could be obtained from patients who were not lost to follow-up and images 
were of sufficient quality for all ultrasound phenotypes.  For the obese subjects, 35 were excluded 
due to poor image quality, for diabetics, 12 were excluded due to poor imaging quality, for the post-
transplant subjects, age was not recorded for 8 patients and they were lost to follow-up and for RA 
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subjects, 6 subjects did not have suitable image quality for analysis.  While imaging measurements 
from the studies in this thesis were performed retrospectively, there is potential to eliminate this 
image quality limitation using semi-automated measurements.  Operators can scan the patient and 
analyze the image with the patient in the room allowing for rescan if image quality is insufficient. 
Limitations were also identified specific to the development of semi-automated TPV measurement.  
While observers measured plaques with the criterion that hyperechoic signal combined with notable 
wall thickening constituted plaque, no objective measure was used to define plaque.  Subsequently, 
this could be a source of observer variability between plaque measurements.  Additionally, while 
TPV has been reported as the sum of plaques in the left and right carotid arteries, in this thesis we 
defined it as the mean of both sides for comparison to VWV which was also determined as the 
mean of left and right arteries.   
 
4.3 Future Work and Clinical Applications 
All of the limitations of our current analysis and results certainly motivate the direction of future 
work.  For example, a better understanding of the clinical meaning of 3DUS imaging measurements 
will require a comparison of 3DUS measurements with clinically established but less indirect 
biomarkers such as c-reactive protein, lipoprotein (a), fibrinogen and homocysteine.  Differences 
observed in relation to traditional ultrasound measurements suggest that 3DUS measures may 
provide unique information pertaining to atherosclerosis.  Further analyses of these semi-automated 
measurements will also help to establish the clinical use of these phenotypes. Prospective studies 
comparing those with mild, moderate and severe disease to sex- and age-matched controls will 
allow us to improve our understanding of the effects of hormones, inflammation and modifiable risk 
factors in carotid artery atherosclerosis. 
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Future work for the development of the semi-automated TPV measurement will focus on improving 
the accuracy of the tool compared to manual segmentation.  While a geometric approach is 
preferred to accurately estimate plaque even when artefacts are present, a level set method could be 
applied exclusively to the axial segmentation boundaries to combine input from the observer with 
voxel information from the image.  Additionally, the optimal number of axial segmentation 
boundaries used to generate a volume will be analyzed to improve overall accuracy. 
Semi-automated total plaque volume is currently being applied in measurements of plaque for two 
studies.  One study is exploring the safety of a commonly prescribed immunosuppressant in 
comparison to traditional standard of care using imaging measures of semi-automated IMT, and 
VWV alongside TPV.  The second study explores the effects of mild to moderate alcohol 
consumption on atherosclerosis using imaging endpoints.  In each study traditional biomarkers such 
as age, cholesterol levels, blood pressure and other traditional cardiovascular risk indicators are 
collected in combination with emerging biomarkers such as c-reactive protein, homocysteine and 
other measurements.  Longitudinal studies such as these will improve our understanding of 3DUS 
measurements and their relationship to cardiovascular events and other biomarkers. 
We hypothesized that three-dimensional ultrasound measurements of carotid atherosclerosis can 
provide a more sensitive estimation of disease burden in vulnerable patient populations than 
traditional measures. In this thesis we have attained our objective of characterizing the relationship 
of three-dimensional ultrasound vessel wall volume with age.  We have demonstrated with age and 
sex a novel relationship between 3D imaging biomarkers that is nonexistent with 1D US 
measurements.  While 3DUS measurements show similar trends of plaque and IMT with age in 
males, this relationship does not exist in females as inflammation may play a larger role in plaque 
development in females.  Secondly, we have developed a novel semi-automated approach for the 
estimation of total carotid plaque volume with similar variability and high agreement with manual 
measurements.  The objectives described here were developed to provide rapid estimation of 
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atherosclerotic disease and improve our understanding of interpreting 3DUS measurements as they 
relate to cerebrovascular event risk.  Development and understanding of current and emerging 
biomarkers will serve to increase our understanding of atherosclerosis as a disease process and lead 
to more effective strategies for prevention, monitoring and treatment of cardiovascular disease. 
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Semi-automated segmentation of carotid artery total plaque volume 
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ABSTRACT 
Carotid artery total plaque volume (TPV) is a three-dimensional (3D) ultrasound (US) imaging measurement of carotid 
atherosclerosis, providing a direct non-invasive and regional estimation of atherosclerotic plaque volume – the direct 
determinant of carotid stenosis and ischemic stroke.  While 3DUS measurements of TPV provide the potential to 
monitor plaque in individual patients and in populations enrolled in clinical trials, until now, such measurements have 
been performed manually which is laborious, time-consuming and prone to intra-observer and inter-observer variability.  
To address this critical translational limitation, here we describe the development and application of a semi-automated 
3DUS plaque volume measurement.  This semi-automated TPV measurement incorporates three user-selected 
boundaries in two views of the 3DUS volume to generate a geometric approximation of TPV for each plaque measured.  
We compared semi-automated repeated measurements to manual segmentation of 22 individual plaques ranging in 
volume from 2mm3 to 151mm3.  Mean plaque volume was 43±40 mm3 for semi-automated and 48±46 mm3 for manual 
measurements and these were not significantly different (p=0.60).  Mean coefficient of variation (CV) was 12.0±5.1% 
for the semi-automated measurements. 
 
Keywords: 3D ultrasound, carotid, total plaque volume, segmentation, semi-automated, validation 
 
1. DESCRIPTION OF PURPOSE 
Carotid atherosclerosis progresses from an initial thickening of the intima and media layers of the arterial wall and 
manifests as complex plaque lesions within the arterial wall and eventual stenosis that can potentially result in ischemic 
stroke1.  In order to monitor plaque development in patients at risk and to track the effects of new therapies direct, non-
invasive and local measurements of plaque are required2-4.  Ultrasound (US) imaging of the carotid arteries provides a 
noninvasive way to monitor the progression and regression of atherosclerosis5,6.  Although several 3DUS imaging 
phenotypes have been developed7, there is currently no way to generate reproducible, direct measurements of plaque in 
real time at the bedside and this is critical for translation of these measurements to clinical use and clinical trials.  Total 
Plaque Area (TPA) is a 2D estimation of plaque in the longitudinal plane8.  While this cross-sectional area provides a 
rapid estimation of plaque area, measurement variability is inherently high because image acquisition depends on 
repeatedly selecting the same representative longitudinal view for each new measurement.  In contrast, Total Plaque 
Volume (TPV) provides a plaque estimation that encompasses the complex geometries and morphologies associated 
with plaque9,10 but manual segmentation is laborious, time-intensive and has high intra- and inter-observer variability.  
Accordingly, our objective was to generate a semi-automated method that can be used in real time for quantifying 
plaque volume with precision similar to manual methods. While TPA (measured in the longitudinal view) and manual 
TPV (measured in the axial view) are measured in a single plane only, our aim was to generate a method that 
incorporated information from both the longitudinal and axial views, maximizing the use of the 3DUS information to 
approximate TPV.  In other words, we aimed to incorporate the longitudinal view - ideal for rapidly identifying the ends 
of a plaque and the cross-sectional axial view measurements – ideal for providing information on plaque morphology in 
our semi-automated approach.  
 
2. METHODS 
2.1 Imaging 
3DUS images of the carotid arteries of ten subjects with carotid stenosis greater than 60% (defined by carotid Doppler 
flow velocities) were evaluated for the measurement of 22 individual plaques in the common and internal carotid 
arteries.  Subjects recruited from The Premature Atherosclerosis Clinic (London Health Sciences Centre, London, 
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Ontario, Canada) provided written informed consent to the protocol approved by the local ethics review board. 
Ultrasound images were acquired using a Philips ATL HDI 5000 machine by translating an 8.5MHz ultrasound 
transducer (L12-5, 50 mm, Philips, Bothell, WA, USA) along the lateral side of the neck.  Parallel 2D images separated 
by 0.15mm were acquired at a uniform speed of 3mm/s for 4.0cm along the neck without cardiac gating.  After 
completing acquisition, all 2D images were reconstructed into a 3D volume. Since the position and orientation of each 
2D image was known, voxel based reconstruction allowed for each 2D image to be transformed within the 3D volume 
as previously described11. 
 
2.2 Manual segmentation 
We used methods previously described for the manual measurement of TPV 41.  Briefly, the user identified the 
bifurcation of the common carotid artery and selected a parallel axis for segmentation in the 3DUS volume.  An Intuos3 
professional pen tablet (Wacom Technology Corporation, Vancouver, WA, USA) was used to manually segment plaque 
boundaries.  Initialization of the measurement occurred in the axial plane whereby the end of the plaque was identified 
and a contour was drawn to generate a cross-sectional area.  Plaque segmentation along the parallel axis at 1mm inter-
slice distances was performed until the entire plaque was measured. Cross-sectional areas were multiplied by the inter-
slice distance to generate volumes for individual plaques.  For each subject, TPV was generated as the sum of all 
plaques measured on the left and right carotid artery.  Manual measurements were timed with a stopwatch initiated after 
setting the bifurcation point. 
 
2.3 Semi-automated segmentation: development and application  
 
 
 
 
Figure 1. 3DUS TPV measurement algorithm pipeline. 
 
The algorithm that we developed to measure TPV semi-automatically takes advantage of the fact that in a 3DUS 
volume, both the longitudinal and axial views provide a way to estimate the ends of each plaque and the morphology 
across each individual plaque.  The algorithm pipeline is summarized in Figure 1.  The first step involved the observer 
using the 3DUS volume in the longitudinal and axial planes to identify the estimated ends of a single plaque visibly 
obvious as echogenic plaque.  The second step involved identification of the estimated midpoint of the plaque in the 
longitudinal plane and a contour generated from this midpoint (Contour 1, C1).   From C1, the minimum and maximum 
values along the z-axis were identified by the algorithm as the end points of the plaque.  To assist with geometric 
approximation of the entire plaque volume, two additional points in the longitudinal view were generated by the user 
(Contour 2, C2 and Contour 3, C3).  Finally, the maximum and minimum z values (end points) were automatically 
joined to 20 points along C2 and C3. 
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Figure 2.  User input for semi-automated TPV measurement.  In the longitudinal view (and with assistance from the axial view, 
not shown) the user identifies the maximum and minimum z-values representing the end points of the plaque (Min Z and Max Z).  
The user identifies the mid-point of the plaque (C1) and finally C2 and C3 are identified and generated.  Uniform plaque geometry 
between C2 and C3 is assumed and a final volume is generated. 
 
The points along C2 and C3 were used as representative vertices (PFj) and linearly interpolated to generate surface 
areas.  The resulting geometric approximation was a polyhedron with several surface areas (Ai) where m faces (Fj) 
labeled F0,…Fm-1 were used to compute a volume12 as shown in equation 1 below.  The time to perform measurements 
was measured automatically using a timer that was built into the measurement software.  The user activated the timer 
prior to beginning the measurement and stopped timing after the algorithm generated a plaque volume. 
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2.4 Evaluation 
As previously described, we defined TPV as the sum of all plaque volumes within a single subject including both 
common and internal carotid arteries. Typically, left and right sides were summed to generate a cumulative TPV for 
each subject.   However, for the analysis presented here, each individual plaque was evaluated independently for 
comparison of manual and semi-automated methods.  Semi-automated measurements for all plaques were repeated five 
times by a single observer who was blinded to study subject identity and for each segmentation round, the order of 
subjects and plaques was randomized.  Semi-automated measurements were compared to manual segmentations using 
linear regression and Bland Altman Analysis.  For an estimation of intra-observer variability, the coefficient of variation 
(CV) for each plaque was generated (standard deviation of five independent measurements divided by the mean) based 
on five repeated semi-automated measurements. 
 
 
 
 
3. RESULTS 
A single observer identified and measured 22 atherosclerotic plaques within 1.5 cm of the carotid bifurcation (1.0 cm 
distal to bifurcation in common carotid artery and 0.5cm proximal to bifurcation in internal carotid artery) in 10 
different subject images (4 left carotid artery and 6 right carotid artery).  Figure 3 provides images of representative 
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segmentation contours generated for manual (red) and semi-automated (yellow) measurement methods in the axial (A) 
and longitudinal (B) views.  The mean TPV measured using the semi-automated measurement 43±40 mm3 was not 
significantly different than the mean TPV obtained using manual measurements 48±46 mm3 (p = 0.60). Table 1 shows 
manual and semi-automated mean plaque volume and repeated measures CV for the semi-automated measurements.  
 
 
 
Figure 3.  Representative manual and semi-automated segmentation boundaries. (A) axial view, (B) longitudinal view.  Manual 
(red) algorithm contours (yellow).  Yellow bar=10mm. 
 
Table 1. Semi-automated and manual measurements for 22 carotid plaques. 
Plaque  
Semi-automated 
Plaque Volume 
mm3 (±SD) 
Mean Semi-
automated Plaque 
Volume 
Segmentation Time 
(min) 
Manual 
Plaque 
Volume 
(mm3) 
 
Manual Plaque 
Volume 
Segmentation 
Time (min) 
 
 
CV Semi-
automated 
(%) 
1 18.7±3.7 2.1±0.8 23.2 4.1 19.6 
2 43.6±4.6 3.9±2.5 44.8 4.8 10.6 
3 7.9±1.2 2.5±1.3 7.5 2.9 14.6 
4 4.9±0.7 2.8±2.2 4.9 2.8 14.7 
5 77.7±10.2 3.4±1.6 87.3 6.0 13.1 
6 30.6±2.0 3.5±1.2 37.4 6.3 6.5 
7 2.5±0.4 1.6±0.6 4.5 3.9 17.6 
8 119.5±11.4 3.4±1.7 137.5 4.5 9.6 
9 139.5±11.1 4.6±3.1 145.4 4.3 8.0 
10 67.5±3.8 2.4±0.5 78.5 3.9 5.6 
11 34.6±3.0 1.8±0.4 41.6 3.2 8.7 
12 72.3±4.5 3.1±2.1 72.4 4.1 6.3 
13 15.4±2.2 2.7±1.0 20.5 3.0 14.5 
14 20.9±2.9 2.2±1.0 24.9 3.1 13.7 
15 12.2±1.9 1.4±0.2 10.8 3.0 15.2 
16 2.0±0.5 2.2±0.6 2.0 2.3 26.6 
17 42.6±1.8 2.3±0.6 34.6 2.9 4.3 
18 35.4±3.4 2.3±0.4 35.0 3.0 9.7 
19 26.7±2.8 2.7±1.4 26.8 3.2 10.4 
20 21.6±2.3 2.6±0.8 34.5 4.4 10.7 
21 121.4±11.6 3.6±1.5 151.4 5.7 9.6 
22 21.3±3.1 2.0±0.7 26.0 5.0 14.5 
Mean 42.7±40.4 2.7±0.8 47.8±45.6 3.9±1.1 12.0±5.1 
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Figure 4 shows the relationship between variability (using CV of each plaque measurement) and mean plaque volume 
(left) and the relationship between manual and semi-automated measurements (right).  The mean coefficient of variation 
for all plaques measured with the semi-automated method was 12±5%. Manual TPV segmentations were significantly 
correlated with semi-automated measurements (r = 0.99, p < 0.0001).  Semi-automated TPV segmentation was 2.7±0.8 
minutes compared to 3.9±1.1 minutes for manual TPV measurements.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Relationship of semi-automated plaque volume and variability of measurement (CV) (left) Relationship between manual 
and Semi-automated measurements (right). 
 
Figure 5 shows Bland Altman analysis of manual compared to semi-automated TPV measurements.  The mean 
difference between semi-automated and manual measurements was represented as a bias of -11.8 %.   
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Figure 5. Bland-Altman Analysis of Agreement between manual and semi-automated TPV.  Percent difference between mean 
semi-automated TPV measurement (SATPV) and manual total plaque volume measurement (MTPV) plotted against the average of 
both measurements.  Limits of agreement within two standard deviations are shown with dotted lines. 
 
4. NEW OR BREAKTHROUGH WORK TO BE PRESENTED 
We developed a semi-automated measurement of carotid atherosclerotic plaque volume for real-time measurements at 
the bedside.  Variability of the semi-automated measurement was similar to manual segmentation methods reported by 
Landry even for plaques in the 50-100mm3 range, more common in moderate disease without stenosis13.  Bland Altman 
and linear regression analysis indicated a bias in semi-automated measurements underestimating manual total plaque 
volumes.  On average, plaque volume was underestimated by approximately 12%. 
 
5. CONCLUSIONS 
We developed a semi-automated segmentation tool to measure 3DUS TPV.  The geometric volume approximation this 
tool provides may provide a more accurate estimate compared to edge detection methods because signal void and 
artifacts, common in 3DUS carotid images would not influence contour shape and plaque morphology using a 
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geometric method. Although the semi-automated measurement of TPV provided an underestimated measurement in 
comparison with manual TPV, this bias may not be clinically significant in longitudinal comparisons.  The 
measurement tool we developed provided a way to estimate plaque burden in real time at the bedside.  Next steps 
include the evaluation of inter-observer variability enabling multiple observers to perform measurements in real-time to 
monitor carotid atherosclerosis.   
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the hospital. 
   Oakville Trafalgar Memorial Hospital, Oakville, Ontario, Canada 
 
05/08-08/08,  PURE Study Clinic Volunteer  
05/07-08/07 Obtained ECG, BMI, spirometry and grip strength measurements. 
Helped administer and guide patients through study surveys. 
Population Health Research Institute, Hamilton, Ontario, Canada 
 
 
TEACHING EXPERIENCE 
 
03/09   ThinkFirst Aviva Brain Day Teacher 
Visited a local elementary school to teach children about how the 
brain functions, what happens when it’s damaged and how to adopt 
life-saving injury prevention habits. 
   Schulich School of Medicine, London, Ontario, Canada 
 
01/08-04/08  Learning it Together Mentor 
Mentored a grade one student from the London community as part of 
an after-school program.   
Faculty of Health Sciences at the University of Western Ontario, 
London, Ontario, Canada  
 
06/07-08/07  Soccer Coach 
   Head coach of the C2 team in the U5 Timbits Soccer division.   
   Oakville Soccer Club, Oakville, Ontario, Canada 
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PROFESSIONAL ASSOCIATIONS 
 
04/10   Biomedical Imaging Research Centre 
Robarts Research Institute at the Schulich School of Medicine, UWO, 
London, Ontario, Canada 
 
10/10 – 10/11 Student Emergency Response Team 
The University of Western Ontario,  
London, Ontario, Canada 
 
04/10- 10/11  London Lung Imaging Research Team 
Robarts Research Institute at the Schulich School of Medicine, UWO, 
London, Ontario, Canada 
 
